<?xml version="1.0" encoding="utf-8"?>
<XML>
<JOURNAL>
<YEAR>2025</YEAR>
<VOL>11</VOL>
<NO>3</NO>
<MOSALSAL>0</MOSALSAL>
<PAGE_NO>276</PAGE_NO>


<ARTICLES>

	<ARTICLE> 
		<TitleF>Clinical Applications of Myrtus communis L. in Traditional and Modern Medicine: A Scoping Review</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Myrtus communis L. (MC), or common myrtle, is a member of the Myrtaceae family and has been widely used in herbal medicine, including Persian medicine (PM), the Unani system, and modern medical research.&#160;
Objectives: This review aimed to explore MC berries, leaves, seeds, and essential oils&#8217; therapeutic and biochemical properties in PM and contemporary scientific studies.
Methods: Modern research was sourced from databases, such as ScienceDirect, Scopus, Embase, and PubMed. PM sources included key traditional textbooks, such as &#8216;the canon of medicine,&#8217; &#8216;Makhzan al-Adviyah,&#8217; and others. The search was based on the keywords Myrtus communis or myrtle in new sources and Mord or Habb-ul-Aas in traditional medicine sources.
Results: In PM, MC has been used for neurological (headaches, epilepsy), ophthalmic (conjunctivitis), head and neck (toothache, earache, gingivitis), respiratory (cough, tuberculosis), gastrointestinal reflux disease (GERD, diarrhea), urogenital (bladder stones, dysuria), and skin conditions (warts, burns, acne). Modern studies have confirmed its efficacy in treating urogenital infections (vaginitis, human papillomavirus [HPV]), skin issues (acne and warts), GERD, and head and neck conditions (aphthous stomatitis). In vivo and in vitro studies have shown antiparasitic, cardiovascular, antibacterial, antiviral, anticancer, and neuroprotective effects (Alzheimer&#8217;s and insomnia).
Conclusion: Modern research has validated many traditional uses of MC; however, further studies are required to confirm its medical benefits comprehensively.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>173</FPAGE>
			<TPAGE>188</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2025/07/12
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1404/4/21
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2025/09/21
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1404/6/30
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Ali</Name>
				<MidName></MidName>
				<Family>Rezaee</Family>
				<NameE>Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rezaee</FamilyE>
				<Organizations>
				<Organization>Student Research Committee, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>alirezaee2510@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohsen</Name>
				<MidName></MidName>
				<Family>Rezaee</Family>
				<NameE>Mohsen</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rezaee</FamilyE>
				<Organizations>
				<Organization>Student Research Committee, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Rezaee.Mohsen.1382@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Zohre</Name>
				<MidName></MidName>
				<Family>Feyzabadi</Family>
				<NameE>Zohre</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Feyzabadi</FamilyE>
				<Organizations>
				<Organization>Dr Feyzabadi Private Practice, Mashhad, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>feyzabadi_8823@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohammad M.</Name>
				<MidName></MidName>
				<Family>Zarshenas</Family>
				<NameE>Mohammad M.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Zarshenas</FamilyE>
				<Organizations>
				<Organization>Department of Phytopharmaceuticals (Traditional Pharmacy), School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>zarm@sums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Myrtus communis (MC)</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Phytotherapy</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Medicine</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Traditional</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>complementary therapies</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Plant</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Özkan AM, Güray ÇG. A Mediterranean: Myrtus communis L.(myrtle). In: Morel JP, Mercuri AM (editors). Plants and culture: Seeds of the cultural heritage of Europe. Bari: Edipuglia: 2009. [Link]##Emami A, Mehregan I, Fasihi Sh. [Medicinal plants reference book (Persian)]. Tehran: Andisheh-e-Noor Publishing; 2010. [Link]##Ghahreman A, Okhovvat AR. [Matching the old medicinal plant names with scientific terminology (Persian)]. Tehran: University of Tehran Press; 2010. [Link]##Avicenna. The Canon of medicine. [F. Esmaieli (Persian trans]. Tehran: Kahkeshane Elm; 2024. [Link]##Aghili Alavi Khorasani Shirazi MH. [Makhzan al-Advieh (Persian)]. Tehran: Chogan; 2014. [Link]##Alipour G, Dashti S, Hosseinzadeh H. Review of pharmacological effects of Myrtus communis L. and its active constituents. Phytother Res. 2014; 28(8):1125-36. [DOI:10.1002/ptr.5122] [PMID]##Jafari Z, Bardania H, Barmak MJ, Eslami S, Mahmoudi-Mourderaz Y, Roustaei N, et al. Antimicrobial, anti‐inflammatory, and wound healing properties of Myrtus communis leaf methanolic extract ointment on burn wound infection induced by methicillin‐resistant staphylococcus aureus in rats. Biomed Res Int. 2024; 2024:6758817. [DOI:10.1155/2024/6758817] [PMID]##Mahboubi M. Myrtus communis L. and its application in treatment of Recurrent Aphthous Stomatitis. J Ethnopharmacol. 2016; 193:481-9. [DOI:10.1016/j.jep.2016.09.054] [PMID]##Harassi Y, Tilaoui M, Idir A, Frédéric J, Baudino S, Ajouaoi S, et al. Phytochemical analysis, cytotoxic and antioxidant activities of Myrtus communis essential oil from Morocco. J Complement Integr Med. 2019 Jan 19;16(3):/j/jcim.2019.16.issue-3/jcim-2018-0100/jcim-2018-0100.xml. [DOI:10.1515/jcim-2018-0100] [PMID]##Al-Snafi AE, Teibo JO, Shaheen HM, Akinfe OA, Teibo TKA, Emieseimokumo N, et al. The therapeutic value of Myrtus communis L. : An updated review. Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(7):4579-600. [DOI:10.1007/s00210-024-02958-3] [PMID]##Kirtikar KR, Basu BD. Indian medicinal plants. Publisher not identified Basu, Bhuwaneśwari Âśrama; 1918. [DOI:10.5962/bhl.title.137025]##Akin M, Aktumsek A, Nostro A. Antibacterial activity and composition of the essential oils of Eucalyptus camaldulensis Dehn. and Myrtus communis L. growing in Northern Cyprus. Afr J Biotechnol. 2010; 9(4). [Link]##Hennia A, Miguel MG, Nemmiche S. Antioxidant activity of Myrtus communis L. and myrtus nivellei batt. &#38; trab. extracts: A brief review. Medicines. 2018; 5(3):89. [DOI:10.3390/medicines5030089] [PMID]##Mimica-Dukić N, Bugarin D, Grbović S, Mitić-Ćulafić D, Vuković-Gačić B, Orčić D, et al. Essential oil of Myrtus communis L. as a potential antioxidant and antimutagenic agents. Molecules. 2010; 15(4):2759-70. [DOI:10.3390/molecules15042759] [PMID]##Sacchetti G, Muzzoli M, Statti G, Conforti F, Bianchi A, Agrimonti C, et al. Intra-specific biodiversity of Italian myrtle (Myrtus communis) through chemical markers profile and biological activities of leaf methanolic extracts. Nat Prod Res. 2007; 21(2):167-79. [DOI:10.1080/14786410600603783] [PMID]##Montoro P, Tuberoso CI, Perrone A, Piacente S, Cabras P, Pizza C. Characterisation by liquid chromatography-electrospray tandem mass spectrometry of anthocyanins in extracts of Myrtus communis L. berries used for the preparation of myrtle liqueur. J Chromatogr A. 2006; 1112(1-2):232-40. [DOI:10.1016/j.chroma.2005.11.055] [PMID]##Montoro P, Tuberoso CI, Piacente S, Perrone A, De Feo V, Cabras P, et al. Stability and antioxidant activity of polyphenols in extracts of Myrtus communis L. berries used for the preparation of myrtle liqueur. J Pharm Biomed Anal. 2006; 41(5):1614-9. [DOI:10.1016/j.jpba.2006.02.018] [PMID]##Serce S, Ercisli S, Sengul M, Gunduz K, Orhan E. Antioxidant activities and fatty acid composition of wild grown myrtle (Myrtus communis L.) fruits. Pharmacogn Mag. 2010; 6(21):9-12. [DOI:10.4103/0973-1296.59960] [PMID]##Sumbul S, Ahmad MA, Asif M, Saud I, Akhtar M. Evaluation of Myrtus communis Linn. berries (common myrtle) in experimental ulcer models in rats. Hum Exp Toxicol. 2010; 29(11):935-44. [DOI:10.1177/0960327110364154] [PMID]##Romani A, Pinelli P, Mulinacci N, Vincieri FF, Tattini M. Identification and quantitation of polyphenols in leaves of Myrtus communis L. Chromatographia. 1999; 49:17-20. [DOI:10.1007/BF02467181]##Usai M, Mulas M, Marchetti M. Chemical composition of essential oils of leaves and flowers from five cultivars of myrtle (Myrtus communis L.). J Essent Oil Res. 2015; 27(6):465-76. [DOI:10.1080/10412905.2015.1065773]##Zomorodian K, Moein M, Lori ZG, Ghasemi Y, Rahimi MJ, Bandegani A, et al. Chemical composition and antimicrobial activities of the essential oil from Myrtus communis leaves. J Essent Oil Bearing Plants. 2013; 16(1):76-84. [DOI:10.1080/0972060X.2013.764183]##Al-Snafi AE. Chemical constituents and pharmacological activities of Milfoil (Achillea santolina)-A Review. Int J Pharm Tech Res. 2013; 5(3):1373-7. [Link]##Franco AM, Tocci N, Guella G, Dell’Agli M, Sangiovanni E, Perenzoni D, et al. Myrtle seeds (Myrtus communis L.) as a rich source of the bioactive ellagitannins oenothein B and eugeniflorin D2. ACS Omega. 2019; 4(14):15966-74. [DOI:10.1021/acsomega.9b02010] [PMID]##Pedanius Dioscorides of Anazarbus. Dioscorides De Materia Medica [Beck LL, English trans]. Hildesheim: Georg Olms Verlag; 2017. [Link]##Ghadami Yazdi E, Minaei MB, Hashem Dabaghian F, Ebrahim Zadeh Ardakani M, Ranjbar AM, Rastegari M, et al. Efficacy of Myrtus communis L. and Descurainia sophia L. versus Salicylic Acid for wart treatment. Iran Red Crescent Med J. 2014; 16(10):e16386. [PMID]##Bagatin E, Thouvenin MD, Bacquey A, Baradat S, Lauze C, Mengeaud V, et al. The usefulness of a dermocosmetic containing Myrtus communis extract and azelaic acid for maintenance phase of adult female acne: Results from a randomized exploratory investigator‐blinded comparative study. J Eur Acad Dermatol Venereol. 2023; 37(Suppl 2):26-30. [DOI:10.1111/jdv.18795] [PMID]##Salmanian M, Shirbeigi L, Hashem-Dabaghian F, Mansouri P, Azizkhani M, Alavi S, et al. The effects of Myrtle (Myrtus communis) and clindamycin topical solution in the treatment of mild to moderate Acne Vulgaris: A comparative split-face study. J Pharmacopuncture. 2020; 23(4):220-9. [DOI:10.3831/KPI.2020.23.4.220] [PMID]##Mirzaee F, Jannesari S, Kariman N, Mojab F, Nasiri M. [The effect of Myrtus communis cream on wound healing and severity of episiotomy pain: Double-blind clinical trial (Persian). Iran J Obstet Gynecology Infertil. 2019; 22(8):52-61. [DOI:10.22038/ijogi.2019.13920]##Chaijan MR, Handjani F, Zarshenas M, Rahimabadi MS, Tavakkoli A. The Myrtus communis L. solution versus ketoconazole shampoo in treatment of dandruff: A double blinded randomized clinical trial. J Pak Med Assoc. 2018; 68(5):715-20. [Link]##Piérard-Franchimont C, Goffin V, Decroix J, Piérard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol. 2002; 15(6):434-41. [DOI:10.1159/000066452] [PMID]##Malekuti J, Mirghafourvand M, Samadi K, Abbasalizadeh F, Khodaei L. Comparison of the effect of Myrtus communis herbal and anti-hemorrhoid ointments on the hemorrhoid symptoms and quality of life in postpartum women with grade I and II internal hemorrhoid: A triple-blinded randomized controlled clinical trial. J Complement Integr Med. 2019; 16(4):20180147. [DOI:10.1515/jcim-2018-0147] [PMID]##Zohalinezhad ME, Hosseini-Asl MK, Akrami R, Nimrouzi M, Salehi A, Zarshenas MM. Myrtus communis L. freeze-dried aqueous extract versus omeprazol in gastrointestinal reflux disease: A double-blind randomized controlled clinical trial. J Evid Based Complementary Altern Med. 2016; 21(1):23-9. [DOI:10.1177/2156587215589403] [PMID]##Paknejad MS, Eftekhari K, Rahimi R, Vigeh M, Naghizadeh A, Karimi M. Myrtle (Myrtus communis L.) fruit syrup for gastroesophageal reflux disease in children: A double‐blind randomized clinical trial. Phytother Res. 2021; 35(11):6369-76. [DOI:10.1002/ptr.7288] [PMID]##Rao CV, Vijayakumar M. Effect of quercetin, flavonoids and α-tocopherol, an antioxidant vitamin on experimental reflux oesophagitis in rats. Eur J Pharmacol. 2008; 589(1-3):233-8. [DOI:10.1016/j.ejphar.2008.04.062] [PMID]##Askari SF, Jahromi BN, Dehghanian A, Zarei A, Tansaz M, Badr P, et al. Effect of a novel herbal vaginal suppository containing myrtle and oak gall in the treatment of vaginitis: a randomized clinical trial. Daru. 2020; 28(2):603-14. [DOI:10.1007/s40199-020-00365-6] [PMID]##Masoudi M, Miraj S, Rafieian-Kopaei M. Comparison of the effects of Myrtus communis L, Berberis vulgaris and metronidazole vaginal gel alone for the treatment of bacterial vaginosis. J Clin Diagn Res. 2016; 10(3):QC04-7. [DOI:10.7860/JCDR/2016/17211.7392] [PMID]##Qaraaty M, Kamali SH, Dabaghian FH, Zafarghandi N, Mokaberinejad R, Mobli M, et al. Effect of myrtle fruit syrup on abnormal uterine bleeding: A randomized double-blind, placebo-controlled pilot study. DARU. 2014; 22(1):45.[DOI:10.1186/2008-2231-22-45] [PMID]##Umarami RBR, Roqaiya M, Quadri MA. Efficacy of Habbul aas (fruits of Myrtus communis) in menorrhagia: A single blinded randomized standard control study. J Complement Integr Med. 2020; 18(1):123-30. [DOI:10.1515/jcim-2018-0235] [PMID]##Nikakhtar Z, Hasanzadeh M, Hamedi SS, Najafi MN, Tavassoli AP, Feyzabadi Z, et al. The efficacy of vaginal suppository based on myrtle in patients with cervicovaginal human papillomavirus infection: A randomized, double‐blind, placebo trial. Phytother Res. 2018; 32(10):2002-8. [DOI:10.1002/ptr.6131] [PMID]##Khalilzadeh S, Eftkhar T, Shirbeigi L, Tabarrai M, Toliyat T, Fayazmanesh S, et al. Efficacy of a vaginal tablet as a Persian medicine product on vulvovaginal candidiasis: A double-blind, randomised, placebo-controlled trial. Pharm Biol. 2020; 58(1):574-80. [DOI:10.1080/13880209.2020.1784236] [PMID]##Xu G, Wu M, Yang L, Liu T. [The observation and evaluation of curative effect of nasal mucosa dryness, hemorrhae and erosion (Chinese)]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021; 35(1):29-33. [PMID]##Babaee N, Mansourian A, Momen-Heravi F, Moghadamnia A, Momen-Beitollahi J. The efficacy of a paste containing Myrtus communis (Myrtle) in the management of recurrent aphthous stomatitis: A randomized controlled trial. Clin Oral Investig. 2010; 14(1):65-70. [DOI:10.1007/s00784-009-0267-3] [PMID]##Czakert J, Kandil FI, Boujnah H, Tavakolian P, Blakeslee SB, Stritter W, et al. Scenting serenity: Influence of essential-oil vaporization on dental anxiety-a cluster-randomized, controlled, single-blinded study (AROMA_dent). Sci Rep. 2024; 14(1):14143. [DOI:10.1038/s41598-024-63657-w] [PMID]##D’Urso G, Montoro P, Lai C, Piacente S, Sarais G. LC-ESI/LTQOrbitrap/MS based metabolomics in analysis of Myrtus communis leaves from Sardinia (Italy). Ind Crops Prod. 2019; 128:354-62. [DOI:10.1016/j.indcrop.2018.11.022]##Soomro S, Mesaik MA, Shaheen F, Khan N, Halim SA, Ul-Haq Z, et al. Inhibitory effects of myrtucommuacetalone 1 (MCA-1) from Myrtus Communis on inflammatory response in mouse macrophages. Molecules. 2019; 25(1):13. [DOI:10.3390/molecules25010013] [PMID]##Cevikelli-Yakut ZA, Ertas B, Sen A, Koyuncuoglu T, Yegen BC, Sener G. Myrtus communis improves cognitive impairment in renovascular hypertensive rats. J Physiol Pharmacol. 2020; 71(5). [PMID]##Aykac A, Ozbeyli D, Uncu M, Ertaş B, Kılınc O, Şen A, et al. Evaluation of the protective effect of Myrtus communis in scopolamine-induced Alzheimer model through cholinergic receptors. Gene. 2019; 689:194-201. [DOI:10.1016/j.gene.2018.12.007] [PMID]##Birhanie MW, Walle B, Rebba K. Hypnotic effect of the essential oil from the leaves of Myrtus communis on mice. Nat Sci Sleep. 2016; 8:267-75. [DOI:10.2147/NSS.S101493] [PMID]##Hajiaghaee R, Faizi M, Shahmohammadi Z, Abdollahnejad F, Naghdibadi H, Najafi F, et al. Hydroalcoholic extract of Myrtus communis can alter anxiety and sleep parameters: a behavioural and EEG sleep pattern study in mice and rats. Pharm Biol. 2016; 54(10):2141-8. [DOI:10.3109/13880209.2016.1148175] [PMID]##Hosseinzadeh H, Khoshdel M, Ghorbani M. Antinociceptive, anti-inflammatory effects and acute toxicity of aqueous and ethanolic extracts of Myrtus communis L. Aerial parts in mice. J Acupunct Meridian Stud. 2011; 4(4):242-7. [DOI:10.1016/j.jams.2011.09.015] [PMID]##Tumen I, Senol FS, Orhan IE. Inhibitory potential of the leaves and berries of Myrtus communis L. (myrtle) against enzymes linked to neurodegenerative diseases and their antioxidant actions. Int J Food Sci Nutr. 2012; 63(4):387-92. [DOI:10.3109/09637486.2011.629178] [PMID]##Kadıoğlu Yaman B, Çevik Ö, Yalman K, Ertaş B, Şen A, Şener G. Myrtus communis subsp. Communis improved cognitive functions in ovariectomized diabetic rats. Gene. 2020; 744:144616. [DOI:10.1016/j.gene.2020.144616] [PMID]##Saraiva C, Silva AC, García-Díez J, Cenci-Goga B, Grispoldi L, Silva AF, et al. Antimicrobial activity of Myrtus communis L. and Rosmarinus officinalis L. essential oils against Listeria monocytogenes in cheese. Foods. 2021; 10(5):1106. [DOI:10.3390/foods10051106] [PMID]##Ertas B, Dorucu D, Gulerturk O, Sen A, Cevik O, Cetinel S, et al. The effect of Myrtus communis L. extract on nephrolithiasis model in rats. North Clin Istanb. 2024; 11(2):91-8.  [DOI:10.14744/nci.2023.09068] [PMID]##Coskunlu B, Koroglu MK, Hersek I, Ertas B, Sen A, Sener G, et al. Ameliorative effects of Myrtus communis L. extract involving the inhibition of oxidative stress on high fat diet-induced testis damage in rats. Biotech Histochem. 2024; 99(3):157-73.  [DOI:10.1080/10520295.2024.2344491] [PMID]##Giuliani C, Moretti RM, Bottoni M, Santagostini L, Fico G, Montagnani Marelli M. The Leaf Essential Oil of Myrtus communis subsp. tarentina (L.) Nyman: From Phytochemical Characterization to Cytotoxic and Antimigratory Activity in Human Prostate Cancer Cells. Plants. 2023; 12(6):1293. [DOI:10.3390/plants12061293] [PMID]##Iskender B, Izgi K, Karaca H, Canatan H. Myrtucommulone-A treatment decreases pluripotency-and multipotency-associated marker expression in bladder cancer cell line HTB-9. J Nat Med. 2015; 69(4):543-54.  [DOI:10.1007/s11418-015-0923-7] [PMID]##Barhouchi B, Menacer R, Bouchkioua S, Mansour A, Belattar N. Compounds from myrtle flowers as antibacterial agents and SARS-CoV-2 inhibitors: In-vitro and molecular docking studies. Arab J Chem. 2023; 16(8):104939.  [DOI:10.1016/j.arabjc.2023.104939] [PMID]##Odeh D, Oršolić N, Berendika M, Đikić D, Domjanić Drozdek S, Balbino S, et al. Antioxidant and anti-atherogenic activities of essential oils from Myrtus communis L. and Laurus nobilis L. in rat. Nutrients. 2022; 14(7):1465. [DOI:10.3390/nu14071465] [PMID]##Ebrahimi F, Mahmoudi J, Torbati M, Karimi P, Valizadeh H. Hemostatic activity of aqueous extract of Myrtus communis L. leaf in topical formulation: In vivo and in vitro evaluations. J Ethnopharmacol. 2020; 249:112398. [DOI:10.1016/j.jep.2019.112398] [PMID]##Kılıç S, Okullu SÖ, Kurt Ö, Sevinç H, Dündar C, Altınordu F, et al. Efficacy of two plant extracts against acne vulgaris: Initial results of microbiological tests and cell culture studies. J Cosmet Dermatol. 2019; 18(4):1061-5.  [DOI:10.1111/jocd.12814] [PMID]##Ruffier d’Epenoux L, Fayoux E, Veziers J, Dagnelie MA, Khammari A, Dréno B, et al. Biofilm of Cutibacterium acnes: a target of different active substances. Int J Dermatol. 2024; 63(11):1541-50.  [DOI:10.1111/ijd.17194] [PMID]##Narzary I, Swarnakar A, Kalita M, Middha SK, Usha T, Babu D, et al. Acknowledging the use of botanicals to treat diabetic foot ulcer during the 21st century: A systematic review. World J Clin Cases. 2023; 11(17):4035-59. [DOI:10.12998/wjcc.v11.i17.4035] [PMID]##Khodaie SA, Emadi F, Naseri M, Kamalinejad M, Riahi SM, Alijaniha F, et al. The Effect of Myrtus communis Aqueous Extract-Containing Gel on Wound Healing in Streptozotocin-Induced Diabetic Rats. Curr Drug Discov Technol. 2021; 18(4):542-7. [DOI:10.2174/1570163817666200712163956] [PMID]##Ozkol H, Tuluce Y, Dilsiz N, Koyuncu I. Therapeutic potential of some plant extracts used in Turkish traditional medicine on streptozocin-induced type 1 diabetes mellitus in rats. J Membr Biol. 2013; 246(1):47-55.  [DOI:10.1007/s00232-012-9503-x] [PMID]##Ozcan O, Ipekci H, Alev B, Ustundag UV, Ak E, Sen A, et al. Protective effect of Myrtle (Myrtus communis) on burn induced skin injury. Burns. 2019; 45(8):1856-63. [DOI:10.1016/j.burns.2019.07.015] [PMID]##Shiratake S, Nakahara T, Iwahashi H, Onodera T, Mizushina Y. Rose myrtle (Rhodomyrtus tomentosa) extract and its component, piceatannol, enhance the activity of DNA polymerase and suppress the inflammatory response elicited by UVB induced DNA damage in skin cells. Mol Med Rep. 2015; 12(4):5857-64.  [DOI:10.3892/mmr.2015.4156] [PMID]##van der Wouden JC, van der Sande R, Kruithof EJ, Sollie A, van Suijlekom-Smit LW, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2017; 5(5):CD004767.   [DOI:10.1002/14651858.CD004767.pub4] [PMID]##Guzzo F, Durán AG, Sanna C, Marasco R, Molfetta N, Buommino E, et al. Gallomyrtucommulones g and h, new phloroglucinol glycosides, from bioactive fractions of Myrtus communis against Staphylococcus species. Molecules. 2022; 27(20):7109. [DOI:10.3390/molecules27207109] [PMID]##Nourzadeh M, Amini A, Fakoor F, Raoof M, Sharififar F. Comparative antimicrobial efficacy of Eucalyptus galbie and Myrtus communis L. extracts, chlorhexidine and sodium hypochlorite against Enterococcus faecalis. Iran Endod J. 2017; 12(2):205-10.  ##Jabri MA, Hajaji S, Omrani A, Ben Youssef M, Sebai H. Myrtle berries seeds prevent dyslipidemia, inflammation, and excessive cardiac reactive oxygen species production in response to high-fat diet-induced obesity. J Med Food. 2023; 26(9):631-40. [DOI:10.1089/jmf.2021.0199] [PMID]##Sakulnarmrat K, Konczak I. Composition of native Australian herbs polyphenolic-rich fractions and in vitro inhibitory activities against key enzymes relevant to metabolic syndrome. Food Chem. 2012; 134(2):1011-9. [DOI:10.1016/j.foodchem.2012.02.217] [PMID]##Saadat S, Beigoli S, Khazdair MR, Amin F, Boskabady MH. Experimental and clinical studies on the effects of natural products on noxious agents-induced lung disorders, a review. Front Nutr. 2022; 9:867914. [DOI:10.3389/fnut.2022.867914] [PMID]##Rapiejko P, Talik P, Jurkiewicz D. New treatment options for acute rhinosinusitis according to EPOS 2020. Otolaryngol Pol. 2021; 76(1):29-39.  [DOI:10.5604/01.3001.0015.7094] [PMID]##Alam MA, Quamri MA, Sofi G, Ayman U, Ansari S, Ahad M. Understanding COVID-19 in the light of epidemic disease described in Unani medicine. Drug Metab Pers Ther. 2020; 35(4). [DOI:10.1515/dmpt-2020-0136] [PMID]##Mehrbod P, Safari H, Mollai Z, Fotouhi F, Mirfakhraei Y, Entezari H, et al. Potential antiviral effects of some native Iranian medicinal plants extracts and fractions against influenza A virus. BMC Complement Med Ther. 2021; 21(1):246.   [DOI:10.1186/s12906-021-03423-x] [PMID] ##Hua H, Li F, Xi Y, Jiao W, Wen S, Tao Z. [To explore the therapeutic effect of myrtle oil, anthocyanin and hyaluronic acid in combination with topical application on allergic rhinitis in rats exposed to PM2.5 (Chinese)]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020; 34(8):719-25. [PMID]##Prall S, Bowles EJ, Bennett K, Cooke CG, Agnew T, Steel A, et al. Effects of essential oils on symptoms and course (duration and severity) of viral respiratory infections in humans: A rapid review. Adv Integr Med. 2020; 7(4):218-21. [DOI:10.1016/j.aimed.2020.07.005] [PMID]##Rajizadeh MA, Najafipour H, Samareh Fekr M, Rostamzadeh F, Jafari E, Bejeshk MA, et al. Anti-Inflammatory and Anti-Oxidative Effects of Myrtenol in the Rats with Allergic Asthma. Iran J Pharm Res. 2019; 18(3):1488-98. [PMID]##Samareh Fekri M, Mandegary A, Sharififar F, Poursalehi HR, Nematollahi MH, Izadi A, et al. Protective effect of standardized extract of Myrtus communis L. (myrtle) on experimentally bleomycin-induced pulmonary fibrosis: Biochemical and histopathological study. Drug Chem Toxicol. 2018; 41(4):408-14. [DOI:10.1080/01480545.2018.1459670] [PMID]##Khadraoui N, Essid R, Damergi B, Fares N, Gharbi D, Forero AM, et al. Myrtus communis leaf compounds as novel inhibitors of quorum sensing-regulated virulence factors and biofilm formation: In vitro and in silico investigations. Biofilm. 2024; 8:100205. [DOI:10.1016/j.bioflm.2024.100205] [PMID]##Kabatas GS, Ertas B, Sen A, Sener G, Ercan F, Akakin D. Histological and biochemical effects of an ethanolic extract of Myrtus communis leaf on the pancreases of rats fed high fat diets. Biotech Histochem. 2024; 99(4):204-15. [DOI:10.1080/10520295.2024.2355212] [PMID]##Knauthe A, Mittag S, Bloch L, Albring KF, Schmidt M, Werz O, et al. Hyperforin and myrtucommulone derivatives act as natural modulators of Wnt/β-catenin signaling in HCT116 colon cancer cells. Int J Mol Sci. 2022; 23(6):2984. [DOI:10.3390/ijms23062984] [PMID]##Mansour RB, Beji RS, Wasli H, Zekri S, Ksouri R, Megdiche-Ksouri W, et al. Gastroprotective effect of microencapsulated Myrtus communis essential oil against ethanol/HCl-induced acute gastric lesions. Molecules. 2022; 27(5):1566. [DOI:10.3390/molecules27051566] [PMID]##Jabri MA, Hajaji S, Rtibi K, Sebai H. Role of anti-inflammatory, reactive oxygen species scavenging activity and nematicidal properties of Myrtle berry seeds on Helminthiasis treatment. J Med Food. 2021; 24(4):377-84. [DOI:10.1089/jmf.2020.0089] [PMID]##Mahmoudvand H, Fallahi S, Mahmoudvand H, Shakibaie M, Harandi MF, Dezaki ES. Efficacy of Myrtus communis L. to inactivate the hydatid cyst protoscoleces. J Invest Surg. 2016; 29(3):137-43. [DOI:10.3109/08941939.2015.1088601] [PMID]##Hedayati A, Khosropanah H, Bazargani A, Abed M, Emami A. Assessing the antimicrobial effect of the essential oil of Myrtus communis on the clinical isolates of Porphyromonas gingivalis: An in vitro study. Jundishapur J Nat Pharm Prod. 2013; 8(4):165-8. [DOI:10.17795/jjnpp-12253] [PMID]##Sateriale D, Facchiano S, Colicchio R, Pagliuca C, Varricchio E, Paolucci M, et al. In vitro synergy of polyphenolic extracts from honey, myrtle and pomegranate against oral pathogens, S. mutans and R. dentocariosa. Front Microbiol. 2020; 11:1465. [DOI:10.3389/fmicb.2020.01465] [PMID]##Torabi I, Sharififar F, Izadi A, Ayatollahi Mousavi SA. Inhibitory effects of different fractions separated from standardized extract of Myrtus communis L. against nystatin-susceptible and nystatin-resistant Candida albicans isolated from HIV positive patients. Heliyon. 2022; 8(3):e09073. [DOI:10.1016/j.heliyon.2022.e09073] [PMID]##Hassan HA, El-Kholy WM, El-Sawi MR, Galal NA, Ramadan MF. Myrtle (Myrtus communis) leaf extract suppresses hepatotoxicity induced by monosodium glutamate and acrylamide through obstructing apoptosis, DNA fragmentation, and cell cycle arrest. Environ Sci Pollut Res Int. 2020; 27(18):23188-98. [DOI:10.1007/s11356-020-08780-7] [PMID]##Ben Hsouna A, Dhibi S, Dhifi W, Mnif W, Ben Nasr H, Hfaiedh N. Chemical composition and hepatoprotective effect of essential oil from Myrtus communis L. flowers against CCL 4-induced acute hepatotoxicity in rats. RSC Adv. 2019; 9(7):3777-87. [DOI:10.1039/C8RA08204A] [PMID]##Ozbeyli D, Sen A, Cilingir Kaya OT, Ertas B, Aydemir S, Ozkan N, et al. Myrtus communis leaf extract protects against cerulein‐induced acute pancreatitis in rats.J Food Biochem. 2020; 44(2):e13130. [DOI:10.1111/jfbc.13130] [PMID]##Hashemipour MA, Lotfi S, Torabi M, Sharifi F, Ansari M, Ghassemi A, et al. Evaluation of the effects of three plant Species (Myrtus Communis L., Camellia Sinensis L., Zataria Multiflora Boiss.) on the Healing Process of Intraoral Ulcers in Rats. J Dent (Shiraz). 2017; 18(2):127-35. [PMID]##Jabri MA, Rtibi K, Sakly M, Marzouki L, Sebai H. Role of gastrointestinal motility inhibition and antioxidant properties of myrtle berries (Myrtus communis L.) juice in diarrhea treatment. Biomed Pharmacother. 2016; 84:1937-44. [DOI:10.1016/j.biopha.2016.11.008] [PMID]##Sisay M, Engidawork E, Shibeshi W. Evaluation of the antidiarrheal activity of the leaf extracts of Myrtus communis Linn (Myrtaceae) in mice model. BMC Complement Altern Med. 2017; 17(1):103. [DOI:10.1186/s12906-017-1625-3] [PMID]##Sen A, Ozkan S, Recebova K, Cevik O, Ercan F, Kervancıoglu Demirci E, et al. Effects of Myrtus communis extract treatment in bile duct ligated rats. J Surg Res. 2016; 205(2):359-67. [DOI:10.1016/j.jss.2016.06.094] [PMID]##Deriu A, Branca G, Molicotti P, Pintore G, Chessa M, Tirillini B, et al. In vitro activity of essential oil of Myrtus communis L. against Helicobacter pylori. Int J Antimicrob Agents. 2007; 30(6):562-3. [DOI:10.1016/j.ijantimicag.2007.07.005] [PMID]##Zaidi SF, Muhammad JS, Shahryar S, Usmanghani K, Gilani AH, Jafri W, et al. Anti-inflammatory and cytoprotective effects of selected Pakistani medicinal plants in Helicobacter pylori-infected gastric epithelial cells. J Ethnopharmacol. 2012; 141(1):403-10. [DOI:10.1016/j.jep.2012.03.001] [PMID]##Belahcene S, Kebsa W, Omoboyowa DA, Alshihri AA, Alelyani M, Bakkour Y, et al. Unveiling the chemical profiling antioxidant and anti-inflammatory activities of algerian myrtus communis l. essential oils, and exploring molecular docking to predict the inhibitory compounds against cyclooxygenase-2. Pharmaceuticals. 2023; 16(10):1343. [DOI:10.3390/ph16101343] [PMID]##Amira S, Dade M, Schinella G, Ríos JL. Anti-inflammatory, anti-oxidant, and apoptotic activities of four plant species used in folk medicine in the Mediterranean basin. Pak J Pharm Sci. 2012; 25(1):65-72. [PMID]##Belahcene S, Kebsa W, Akingbade TV, Umar HI, Omoboyowa DA, Alshihri AA, et al. Chemical composition antioxidant and anti-inflammatory activities of Myrtus communis L. leaf extract: forecasting ADMEt profiling and anti-inflammatory targets using molecular docking tools. Molecules. 2024; 29(4):849. [DOI:10.3390/molecules29040849] [PMID]##Maxia A, Frau MA, Falconieri D, Karchuli MS, Kasture S. Essential oil of Myrtus communis inhibits inflammation in rats by reducing serum IL-6 and TNF-α. Nat Prod Commun. 2011; 6(10):1934578X1100601034. [DOI:10.1177/1934578X1100601034]##Mir MA, Bashir N, Alfaify A, Oteef MDY. GC-MS analysis of Myrtus communis extract and its antibacterial activity against gram-positive bacteria. BMC Complement Med Ther. 2020; 20(1):86. [DOI:10.1186/s12906-020-2863-3] [PMID]##Hayani M, Benabbouha T, Naceiri Mrabti N, Eljebri S, Sabiri M, Zair T. Bioactive profiling, antibacterial efficacy and computational modelling of Myrtus communis essential oil (Morocco). Chem Biodivers. 2024; 21(6):e202302114.[DOI:10.1002/cbdv.202302114] [PMID]##Polat Yemiş G, Sezer E, Sıçramaz H. Inhibitory effect of sodium alginate nanoemulsion coating containing myrtle essential oil (Myrtus communis L.) on listeria monocytogenes in Kasar Cheese. Molecules. 2022; 27(21):7298. [DOI:10.3390/molecules27217298] [PMID]##Fadil M, Fikri-Benbrahim K, Rachiq S, Ihssane B, Lebrazi S, Chraibi M, et al. Combined treatment of Thymus vulgaris L., Rosmarinus officinalis L. and Myrtus communis L. essential oils against Salmonella typhimurium: Optimization of antibacterial activity by mixture design methodology. Eur J Pharm Biopharm. 2018; 126:211-20. [DOI:10.1016/j.ejpb.2017.06.002] [PMID]##Hesami D, Ghaffarifar F, Dalimi A, Dayer MS, Nasiri V, Sheikh S. Investigating in vivo and in vitro effects of ethanolic and aqueous extracts of Myrtle (Myrtus communis) on Leishmania major. Iran J Parasitol. 2021; 16(4):641-51. [DOI:10.18502/ijpa.v16i4.7877] [PMID]##Et-Tazy L, Lamiri A, Satia L, Essahli M, Krimi Bencheqroun S. In vitro antioxidant and antifungal activities of four essential oils and their major compounds against post-harvest fungi associated with chickpea in storage. Plants. 2023; 12(20):3587. [DOI:10.3390/plants12203587] [PMID]## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Anti-aging Effects of Salvia officinalis Extract via Telomerase Modulation and Oxidative Stress Reduction</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Aging is a biological process that reduces quality of life and is related to a time-dependent decline in cellular function. It is a primary risk factor for many disorders. Aging-related disorders have become a global healthcare challenge.
Objectives: The present study aimed to investigate the impact of Saliva officinalis on aged tissues.
Methods: In the current study, 30 aged male rats (twenty-month-old) were divided into three groups: Aging, aging-low S. officinalis (100 mg/kg), and aging-high S. officinalis (200 mg/kg). S. officinalis was gavage for 2 weeks. Finally, all aged animals were sacrificed, and the heart, liver, hippocampus, and right kidney tissues were collected for oxidative stress assessment. Blood samples were collected to measure the levels of urea, creatinine, liver enzymes, oxidants, and antioxidants, and telomerase enzyme activity.
Results: The results showed that S. officinalis administration in high doses significantly decreased oxidative stress in aged tissues. Urea and creatinine levels in the aging-high S. officinalis group significantly reduced compared to the aging group. An insignificant change is observed in aspartate aminotransferase (AST), while the alanine aminotransferase (ALT) significantly decreased in the aging-high S. officinalis group. Using S. officinalis in low and high doses notably increased telomerase enzyme activity.&#160;
Conclusion: This study suggests that administering S. officinalis, especially at a high dose (200 mg/kg), can be useful in reducing aging-related impairment.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>189</FPAGE>
			<TPAGE>200</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2025/07/122025/01/25
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1403/11/6
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2025/09/212025/07/19
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1404/4/28
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Shabnam</Name>
				<MidName></MidName>
				<Family>Mohammadi</Family>
				<NameE>Shabnam</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mohammadi</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy and Cell Biology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mohammadish@mums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Negar</Name>
				<MidName></MidName>
				<Family>Ostadrahimi</Family>
				<NameE>Negar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ostadrahimi</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy and Cell Biology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>n.ostadrahimi74@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Abolfazl</Name>
				<MidName></MidName>
				<Family>Rezaei</Family>
				<NameE>Abolfazl</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rezaei</FamilyE>
				<Organizations>
				<Organization>Department of Anatomy and Cell Biology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>rezaeiA@mums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Aging</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Saliva officinalis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Oxidative stress</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Cai Y, Song W, Li J, Jing Y, Liang C, Zhang L, et al. The landscape of aging. Sci China Life Sci. 2022; 65(12):2354-454. [DOI:10.1007/s11427-022-2161-3] [PMID]##Guillaumet-Adkins A, Yañez Y, Peris-Diaz MD, Calabria I, Palanca-Ballester C, Sandoval J. Epigenetics and Oxidative Stress in Aging. Oxid Med Cell Longev. 2017; 2017:9175806. [DOI:10.1155/2017/9175806] [PMID]##Salmon AB, Richardson A, Pérez VI. Update on the oxidative stress theory of aging: Does oxidative stress play a role in aging or healthy aging? Free Radic Biol Med. 2010; 48(5):642-55. [DOI:10.1016/j.freeradbiomed.2009.12.015] [PMID]##Newsholme P, Rebelato E, Abdulkader F, Krause M, Carpinelli A, Curi R. Reactive oxygen and nitrogen species generation, antioxidant defenses, and β-cell function: A critical role for amino acids. J Endocrinol. 2012; 214(1):11-20. [DOI:10.1530/JOE-12-0072] [PMID]##Yamaguchi R, Perkins G. Dynamics of mitochondrial structure during apoptosis and the enigma of Opa1. Biochim Biophys Acta. 2009; 1787(8):963-72. [DOI:10.1016/j.bbabio.2009.02.005] [PMID]##Gavia-García G, Rosado-Pérez J, Arista-Ugalde TL, Aguiñiga-Sánchez I, Santiago-Osorio E, Mendoza-Núñez VM. Telomere Length and Oxidative Stress and Its Relation with Metabolic Syndrome Components in the Aging. Biology (Basel). 2021; 10(4):253. [DOI:10.3390/biology10040253] [PMID]##Kozakiewicz M, Kornatowski M, Krzywińska O, Kędziora-Kornatowska K. Changes in the blood antioxidant defense of advanced age people. Clin Interv Aging. 2019; 14:763-71.[DOI:10.2147/CIA.S201250] [PMID]##Ramesh T, Kim SW, Sung JH, Hwang SY, Sohn SH, Yoo SK, et al. Effect of fermented Panax ginseng extract (GINST) on oxidative stress and antioxidant activities in major organs of aged rats. Exp Gerontol. 2012; 47(1):77-84. [DOI:10.1016/j.exger.2011.10.007] [PMID]##Ghorbani A, Esmaeilizadeh M. Pharmacological properties of Salvia officinalis and its components. J Tradit Complement Med. 2017; 7(4):433-40. [DOI:10.1016/j.jtcme.2016.12.014] [PMID]##Zare, H. Effects of salvia officinalis extract on the breast cancer cell line. SciMed J. 2019; 1(1):25-9. [DOI:10.28991/SciMedJ-2019-0101-4]##El Euch SK, Hassine D, Cazaux S, Bouzouita N, Bouajila J. Salvia officinalis essential oil: Chemical analysis and evaluation of anti-enzymatic and antioxidant bioactivities. S Afr J Bot. 2019; 120:253-60. [DOI:10.1016/j.sajb.2018.07.010]##Kolac UK, Ustuner MC, Tekin N, Ustuner D, Colak E, Entok E. The Anti-Inflammatory and antioxidant effects of salvia officinalis on lipopolysaccharide-induced inflammation in rats. J Med Food. 2017; 20(12):1193-1200. [DOI:10.1089/jmf.2017.0035] [PMID]##Vafaei A, Mohammadi S, Fazel A, Soukhtanloo M, Mohammadipour A, Beheshti F. Effects of carob (Ceratonia siliqua) on sperm quality, testicular structure, testosterone level and oxidative stress in busulfan-induced infertile mice. Pharm Sci. 2018; 24(2):104-11. [DOI:10.15171/PS.2018.16]##Bagheri Y, Keshtmand Z, Rahbarghazi R, Gharamaleki MN, Barati A, Bagheri S, et al. Salvia officinalis hydroalcoholic extract improved reproduction capacity and behavioral activity in rats exposed to immobilization stress. Anim Sci J. 2020; 91(1):e13382. [DOI:10.1111/asj.13382] [PMID]##Dinel AL, Lucas C, Guillemet D, Layé S, Pallet V, Joffre C. Chronic supplementation with a mix of salvia officinalis and salvia lavandulaefolia improves morris water maze learning in normal adult C57Bl/6J mice. Nutrients. 2020; 12(6):1777. [DOI:10.3390/nu12061777] [PMID]##Jalilvand N, Hosseini M, Beheshti F, Ebrahimzadeh-Bideskan A. Protective effect of PPARγ agonist pioglitazone, on testicular tissue and sperm parameters in hypothyroid rats. Toxin Rev. 2019; 40(3):267-76. [DOI:10.1080/15569543.2018.1564775]##Pallio G, Micali A, Benvenga S, Antonelli A, Marini HR, Puzzolo D, et al. Myo-inositol in the protection from cadmium-induced toxicity in mice kidney: An emerging nutraceutical challenge. Food Chem Toxicol. 2019; 132:110675. [DOI:10.1016/j.fct.2019.110675] [PMID]##Osatd-Rahimi N, Saburi E, Karimi S, Boustan A, Ebrahimzadeh-Bideskan A. The therapeutic effect of melatonin on female offspring ovarian reserve and quality in BALB/c mice after exposing their mother to methamphetamine during pregnancy and lactation. Iran J Basic Med Sci. 2023; 26(2):208-15. [PMID]##Yazdi HB, Hojati V, Shiravi A, Hosseinian S, Vaezi G, Hadjzadeh MA. Liver dysfunction and oxidative stress in streptozotocin-induced diabetic rats: Protective role of artemisia turanica. J Pharmacopuncture. 2019; 22(2):109-14. [DOI:10.3831/KPI.2019.22.014] [PMID]##Gaharwar US, Meena R, Rajamani P. Iron oxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in lymphocytes. J Appl Toxicol. 2017; 37(10):1232-44. [DOI:10.1002/jat.3485] [PMID]##Pars Azmon Co. [GPT (ALAT) quantitative detection kit in serum or plasma by photometric method (Persian)]. Karaj: Pars Azmon Co: 2020. [Link]##Pars Azmon Co. [UV urea quantitative detection kit in serum, plasma and urine using photometric method (Persian)]. Karaj: Pars Azmon Co: 2020. [Link]##Pars Azmon Co. [Creatinine quantitative detection kit in serum, plasma or urine using photometric method (Persian)]. Karaj: Pars Azmon Co: 2020. [Link]##Fahmy MA, Diab KA, Abdel-Samie NS, Omara EA, Hassan ZM. Carbon tetrachloride induced hepato/renal toxicity in experimental mice: Antioxidant potential of Egyptian Salvia officinalis L essential oil. Environ Sci Pollut Res Int. 2018; 25(28):27858-76. [DOI:10.1007/s11356-018-2820-6] [PMID]##AlDehaini DMB, Al-Bustan SA, Ali ME, Malalla ZHA, Sater M, Giha HA. Shortening of the leucocytes' telomeres length in T2DM independent of age and telomerase activity. Acta Diabetol. 2020; 57(11):1287-95. [DOI:10.1007/s00592-020-01550-4] [PMID]##Halim M, Halim A. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metab Syndr. 2019; 13(2):1165-72. [DOI:10.1016/j.dsx.2019.01.040] [PMID]##Uwa LM. The anti-aging efficacy of antioxidants. Curr Trends Biomedical Eng Biosci. 2017; 7(4):555716. [DOI:10.19080/CTBEB.2017.07.555716]##Vosoughi N, Gomarian M, Pirbalouti AG, Khaghani S, Malekpoor F. Essential oil composition and total phenolic, flavonoid contents, and antioxidant activity of sage (Salvia officinalis L.) extract under chitosan application and irrigation frequencies. Ind Crops Prod. 2018; 117:366-74. [DOI:10.1016/j.indcrop.2018.03.021]##Khiya Z, Oualcadi Y, Gamar A, Berrekhis F, Zair T, Hilali F. Correlation of total polyphenolic content with antioxidant activity of hydromethanolic extract and their fractions of the Salvia officinalis leaves from different regions of Morocco. J Chem. 2021; 1-11. [DOI:10.1155/2021/8585313]##Barrera G, Pizzimenti S, Daga M, Dianzani C, Arcaro A, Cetrangolo GP, et al. Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders. Antioxidants (Basel). 2018; 7(8):102. [DOI:10.3390/antiox7080102] [PMID]##Zhang Y, Chen X, Yang L, Zu Y, Lu Q. Effects of rosmarinic acid on liver and kidney antioxidant enzymes, lipid peroxidation and tissue ultrastructure in aging mice. Food Funct. 2015; 6(3):927-31. [DOI:10.1039/C4FO01051E] [PMID]##Sener S, Akbas A, Kilinc F, Baran P, Erel O, Aktas A. Thiol/disulfide homeostasis as a marker of oxidative stress in rosacea: A controlled spectrophotometric study. Cutan Ocul Toxicol. 2019; 38(1):55-8. [DOI:10.1080/15569527.2018.1517124] [PMID]##Ahangarpour A, Najimi SA, Farbood Y. Effects of Vitex agnus-castus fruit on sex hormones and antioxidant indices in a d-galactose-induced aging female mouse model. J Chin Med Assoc. 2016; 79(11):589-96. [DOI:10.1016/j.jcma.2016.05.006] [PMID]##Osman N, Abd El-Azime AS. Salvia officinalis L.(Sage) ameliorates radiation-induced oxidative brain damage in rats. Arab. J Nucl Sci Appl. 2013; 46(1):297-304. [Link]##Han X, Bao X, Lou Q, Xie X, Zhang M, Zhou S, et al. Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice. PeerJ. 2019; 7:e7568. [DOI:10.7717/peerj.7568] [PMID]##Rashwan HM, Mohammed HE, El-Nekeety AA, Hamza ZK, Abdel-Aziem SH, Hassan NS, et al. Bioactive phytochemicals from Salvia officinalis attenuate cadmium-induced oxidative damage and genotoxicity in rats. Environ Sci Pollut Res Int. 2021; 28(48):68498-512. [DOI:10.1007/s11356-021-15407-y] [PMID]##Jedidi S, Aloui F, Selmi S, Selmi H, Sammari H, Ayari A, et al. Antioxidant properties of salvia officinalis decoction extract and mechanism of its protective effects on ethanol-induced liver and kidney injuries. J Med Food. 2022; 25(5):546-56. [DOI:10.1089/jmf.2021.0134] [PMID]##Bahri F, Khaksari M, Movahedinia S, Shafiei B, Rajizadeh MA, Nazari-Robati M. Improving SIRT1 by trehalose supplementation reduces oxidative stress, inflammation, and histopathological scores in the kidney of aged rats. J Food Biochem. 2021; 45(10):e13931. [DOI:10.1111/jfbc.13931] [PMID]##Tsoukalas D, Buga AM, Docea AO, Sarandi E, Mitrut R, Renieri E, et al. Reversal of brain aging by targeting telomerase: A nutraceutical approach. Int J Mol Med. 2021; 48(5):199. [DOI:10.3892/ijmm.2021.5032] [PMID]## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Antifibroid and High-performance Liquid Chromatography Analysis of Azadirachta indica (Meliaceae) Leaves</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Globally, women&#8217;s reproductive health is endangered due to fibroids, benign tumors that develop from the uterine smooth muscle cells. Women are increasingly turning to herbal remedies to treat uterine fibroids due to the disadvantages of conventional therapies. Among these plants, the leaves of Azadirachta indica are particularly noteworthy.&#160;
Objectives: This study aimed to evaluate the antifibroid potential of the ethanol leaf extract of A. indica (Meliaceae) in Wistar rats.
Methods: Rats were administered monosodium glutamate (MSG) daily for 30 days to induce the formation of spindle-shaped fibers characteristic of fibroids. The extract was administered in graded doses to a second group as a prophylactic measure concurrently with MSG (preventive approach). In the curative approach, MSG was administered for 30 days to induce fibroid cell formation, following which the extract was administered. Total cholesterol, protein, estrogen, and progesterone levels were measured using biochemical analysis of blood serum. Uterine histopathological examination was performed. High-performance liquid chromatography (HPLC) was employed to identify the bioactive components of the plant.
Results: MSG elevated serum cholesterol (P&#8804;0.05), progesterone (P&#8804;0.001), and estradiol levels in rats. Extract administration inhibited the rise in these parameters, both in the preventive and curative experiments. Histopathology assessment of the rat uterus treated with the extract revealed a reduction in fibroid cells at the 80 mg/kg dose. HPLC analysis identified &#946;-caryophyllin, azadirachnol, azadirachta-A, and quercetin as the major phenolic compounds in the extract.
Conclusion: These findings demonstrate the antifibroid potential of A. indica leaves which merits further research.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>201</FPAGE>
			<TPAGE>214</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2025/07/122025/01/252025/02/17
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1403/11/29
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2025/09/212025/07/192025/08/16
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1404/5/25
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Rose</Name>
				<MidName></MidName>
				<Family>Osarieme Imade</Family>
				<NameE>Rose</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Osarieme Imade</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacognosy, Faculty of Pharmacy, University of Benin, Benin, Nigeria.</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>rose.jesuorobo@uniben.edu</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Buniyamin Adesina</Name>
				<MidName></MidName>
				<Family>Ayinde</Family>
				<NameE>Buniyamin Adesina</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ayinde</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacognosy, Faculty of Pharmacy, University of Benin, Benin, Nigeria.</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>baayinde@uniben.edu</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Andrex Osatohanmwen</Name>
				<MidName></MidName>
				<Family>Iyawe</Family>
				<NameE>Andrex Osatohanmwen</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Iyawe</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacognosy, Faculty of Pharmacy, University of Benin, Benin, Nigeria.</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>iyaweosatohanmwen@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Charles Osemwegie</Name>
				<MidName></MidName>
				<Family>Ogbemudia</Family>
				<NameE>Charles Osemwegie</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ogbemudia</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacognosy, Faculty of Pharmacy, University of Benin, Benin, Nigeria.</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>osemwegie.charles18@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Azadirachta indica</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Fibroid</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>High-performance liquid chromatography (HPLC)</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Histology</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hormones</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Chen HY, Lin PH, Shih YH, Wang KL, Hong YH, Shieh TM, et al. Natural antioxidant resveratrol suppresses uterine fibroid cell growth and extracellular matrix formation in vitro and in vivo. Antioxidants (Basel). 2019; 8(4):99.[DOI:10.3390/antiox8040099] [PMID]##Farris M, Bastianelli C, Rosato E, Brosens I, Benagiano G. Uterine fibroids: An update on current and emerging medical treatment options. Ther Clin Risk Manag. 2019; 15:157-78. [DOI:10.2147/TCRM.S147318] [PMID]##Koltsova AS, Pendina AA, Malysheva OV, Trusova ED, Staroverov DA, Yarmolinskaya MI, et al. In vitro effect of estrogen and progesterone on cytogenetic profile of uterine leiomyomas. Int J Mol Sci. 2024; 26(1):96. [DOI:10.3390/ijms26010096] [PMID]##Arip M, Yap VL, Rajagopal M, Selvaraja M, Dharmendra K, Chinnapan S. Evidence-based management of uterine fibroids with botanical drugs-A review. Front Pharmacol. 2022; 13:878407. [DOI:10.3389/fphar.2022.878407] [PMID]##Liu JP, Yang H, Xia Y, Cardini F. Herbal preparations for uterine fibroids. Cochrane Database Syst Rev. 2009; (2):CD005292. [DOI:10.1002/14651858.CD005292.pub2] [PMID]##Yashunina M. A study of the effect of an ethanolic extract of femitol on uterine fibroid in laboratory model. J Pharmacogn Nat Prod. 2021; 7:6. [Link]##Innocent Ndubuisi Ezejiofor T, Henry Okoroafor C. Effects of ethanol extracts of Diodia sarmentosa leaves on biochemical and histopathological indices of monosodium glutamate-induced uterine leiomyoma in rats. Biomed Res Ther. 2022; 9(7):5140-8. [DOI:10.15419/bmrat.v9i7.749]##Ujah II, Nsude CA, Ani ON, Alozieuwa UB, Okpako IO, Okwor AE. Phytochemicals of neem plant (Azadirachta indica) explains its use in traditional medicine and pest control. GSC Biol Pharm Sci. 2021; 14(2):165-71. [DOI:10.30574/gscbps.2021.14.2.0394]##Su X, Liang Z, Xue Q, Liu J, Hao X, Wang C. A comprehensive review of azadirachtin: physicochemical properties, bioactivities, production, and biosynthesis. Acupunct Herb Med. 2023; 3:256-70. [DOI:10.1097/HM9.0000000000000086]##Aworinde DO, Erinoso SM, Ibukunoluwa MR, Teniola SA. Herbal concoctions used in the management of some women-related health disorders in Ibadan, Southwestern Nigeria. J Appl Biosci. 2020; 147(1):15091-9. [Link]##Alhassan HM, Haruna Yeldu M, Musa U, Adamu I, Marafa AH, Abdullahi H. Acute Toxicity and the Effects of Mangifera indica on Serum IL-6, and IFN-γ in Breast Cancer-Induced Albino Rats. Clin Oncol Res. 2021; 2021:1-6. [Link]##Tepongning RN, Mbah JN, Avoulou FL, Jerme MM, Ndanga EK, Fekam FB. Hydroethanolic Extracts of Erigeron floribundus and Azadirachta indica Reduced Plasmodium berghei Parasitemia in Balb/c Mice. Evid Based Complement Alternat Med. 2018; 2018:5156710. [DOI:10.1155/2018/5156710] [PMID]##Siti-Arffah K, Ridzuan PM, Nurkhaliesah M. Effect of some medicinal plants extract on monosodium glutamate induced uterine fibroid: A review. Eur J Mol Clin Med. 2020; 7(11):490-5. [Link]##Zakaria N, Mohd KS, Ahmed Saeed MA, Ahmed Hassan LE, Shafaei A, Al-Suede FSR, et al. Anti-Uterine fibroid effect of standardized labisia pumila var. alata extracts in vitro and in human uterine fibroid cancer xenograft model. Asian Pac J Cancer Prev. 2020; 21(4):943-51. [DOI:10.31557/APJCP.2020.21.4.943] [PMID]##Lin Y, Yang C, Tang J, Li C, Zhang ZM, Xia BH, et al. Characterization and anti-uterine tumor effect of extract from Prunella vulgaris L. BMC Complement Med Ther. 2020; 20(1):189. [DOI:10.1186/s12906-020-02986-5] [PMID]##Brígido HPC, Varela ELP, Gomes ARQ, Bastos MLC, de Oliveira Feitosa A, do Rosário Marinho AM, et al. Evaluation of acute and subacute toxicity of ethanolic extract and fraction of alkaloids from bark of Aspidosperma nitidum in mice. Sci Rep. 2021; 11(1):18283. [DOI:10.1038/s41598-021-97637-1] [PMID]##Tripathi IP, Mishra MK, Pardhi Y, Dwivedi A, Dwivedi N, Kamal A, et al. HPLC analysis of methanolic extract of some medicinal plant leaves of myrtaceae family. Int Pharm Sci. 2012; 2(3):49-53. [Link]##Zakaria N, Mohd KS, Ali M, Saeed A, Ismail Z. cytotoxicity analysis against uterine fibroid cells preparation of standardized plant extracts. Biosci Res. 2018; 16(1):257-64.##Bonazza C, Andrade SS, Sumikawa JT, Batista FP, Paredes-Gamero EJ, Girão MJ, et al. Primary Human Uterine Leiomyoma Cell Culture Quality Control: Some properties of myometrial cells cultured under serum deprivation conditions in the presence of ovarian steroids. PLoS One. 2016; 11(7):e0158578.  [DOI:10.1371/journal.pone.0158578] [PMID]##Lin PH, Shih CK, Yen YT, Chiang W, Hsia SM. Adlay (Coix lachryma-jobi L. var. ma-yuen Stapf.) Hull Extract and Active Compounds Inhibit Proliferation of Primary Human Leiomyoma Cells and Protect against Sexual Hormone-Induced Mice Smooth Muscle Hyperproliferation. Molecules. 2019; 24(8):1556.  [DOI:10.3390/molecules24081556] [PMID]##Ahmed I, Ahmed N, Ahmed S, Ahmad F, Al-Subaie AM. Effect of emblica officinalis (Amla) on monosodium glutamate (MSG) induced uterine fibroids in wistar rats. Res J Pharm Technol 2020; 13(6):2535-9.  [DOI:10.5958/0974-360X.2020.00451.5]##Li ZL, Huang TY, Ho Y, Shih YJ, Chen YR, Tang HY, et al. Herbal medicine in uterine fibroid. In: Abduljabbar H, editor. Fibroids. Rijeka: IntechOpen; 2021. [DOI:10.5772/intechopen.94101]##Ali M, Ciebiera M, Vafaei S, Alkhrait S, Chen HY, Chiang YF, et al. Progesterone signaling and uterine fibroid pathogenesis; molecular mechanisms and potential therapeutics. Cells. 2023; 12(8):1117. [DOI:10.3390/cells12081117] [PMID]##Donnez J. Uterine Fibroids and Progestogen Treatment: Lack of evidence of its efficacy: A review. J Clin Med. 2020; 9(12):3948.  [DOI:10.3390/jcm9123948] [PMID]##Koyejo OD, Rotimi OA, Abikpa EN, Bello OA, Rotimi SO. A review of the anti-fibroid potential of medicinal plants: Mechanisms and targeted signaling pathways. Trop J Nat Prod Res. 2021; 5(5):792-804.  [DOI:10.26538/tjnpr/v5i5.1]##AlAshqar A, Lulseged B, Mason-Otey A, Liang J, Begum UAM, Afrin S, et al. Oxidative Stress and Antioxidants in Uterine Fibroids: Pathophysiology and Clinical Implications. Antioxidants. 2023; 12(4):807.   [DOI:10.3390/antiox12040807] [PMID]##Szydłowska I, Nawrocka-Rutkowska J, Brodowska A, Marciniak A, Starczewski A, Szczuko M. Dietary natural compounds and vitamins as potential cofactors in uterine fibroids growth and development. Nutrients. 2022; 14(4):734.  [DOI:10.3390/nu14040734] [PMID]## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Inhibition of Biofilms by Extracts From Vernonia adoensis in Pseudomonas aeruginosa and Staphylococcus aureus</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Bacteria that form biofilms have become a leading cause of increased morbidity and mortality in healthcare settings, as they are responsible for over 65% of nosocomial infections. Biofilms are a major cause of drug resistance in bacteria. Pseudomonas aeruginosa and Staphylococcus aureus are opportunistic pathogens that cause numerous infections and are known for their ability to produce biofilms. Vernonia adoensis is an African ethnomedicinal plant commonly used to treat various disease conditions and has been shown to have antibacterial activity.&#160;
Objectives: This study aimed to investigate the effects V. adoensis extract on biofilms formed by P. aeruginosa and S. aureus and to determine the phytochemicals present in the extract.&#160;
Methods: The effect of the extract on the biofilms of P. aeruginosa and S. aureus was determined on 96-microwell plates using crystal violet. The phytochemical constituents of the extract were determined using ultra-performance liquid chromatography-mass spectroscopy (UPLC-MS).&#160;
Results: The extract disrupted the biofilms of the bacteria. At 100 &#181;g/mL, the extract inhibited the formation of P. aeruginosa and S. aureus biofilms by 93% and 17%, respectively. V. adoensis was more potent in decreasing the attachment efficiency of the biofilm of P. aeruginosa as it caused the detachment of 84% of the biofilm in the presence of safety data sheets (SDS), but only 17% of the biofilm of S. aureus. Five compounds (kaempferol, quinic acid, caffeic acid, rhamnetin I, and luteolin were identified using UPLC-MS. Some of these compounds have demonstrated antimicrobial activity.&#160;
Conclusion: V. adoensis contains bioactive components that may be exploited as lead compounds for the development of new antimicrobial agents with antibiofilm activity.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>215</FPAGE>
			<TPAGE>226</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2025/07/122025/01/252025/02/172023/06/8
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/3/18
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2025/09/212025/07/192025/08/162025/04/26
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1404/2/6
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Winnie</Name>
				<MidName></MidName>
				<Family>Mozirandi</Family>
				<NameE>Winnie</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mozirandi</FamilyE>
				<Organizations>
				<Organization>Department of Biotechnology and Biochemistry, University of Zimbabwe, Harare, Zimbabwe.</Organization>
				</Organizations>
				<Countries>
				<Country>Zimbabwe</Country>
				</Countries>
				<EMAILS>
				<Email>mozirandi@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Godloves Chi</Name>
				<MidName></MidName>
				<Family>Fru</Family>
				<NameE>Godloves Chi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fru</FamilyE>
				<Organizations>
				<Organization>Department of Chemistry, University of Buea, Buea, Cameroon.</Organization>
				</Organizations>
				<Countries>
				<Country>Cameroon</Country>
				</Countries>
				<EMAILS>
				<Email>chigfru@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Stanley</Name>
				<MidName></MidName>
				<Family>Mukanganyama</Family>
				<NameE>Stanley</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mukanganyama</FamilyE>
				<Organizations>
				<Organization>Department of Biotechnology and Biochemistry, University of Zimbabwe, Harare, Zimbabwe.</Organization>
				</Organizations>
				<Countries>
				<Country>Zimbabwe</Country>
				</Countries>
				<EMAILS>
				<Email>smukanganyama@medic.uz.ac.zw</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Biofilm</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Vernonia adoensis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Crystal violet</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Phytochemical</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Spectrometry</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Ara N, Nur MH, Amran MS, Wahid MI, Ahmed M. In vitro antimicrobial and cytotoxic activities of leaves and flowers extracts from Lippia alba. Pak J Biol Sci. 2009; 12(1):87-90. [DOI:10.3923/pjbs.2009.87.90] [PMID]##Tiwari N, Rajdev S, Mullan S. Resistance trends among Pseudomonas aeruginosa isolates in a tertiary care centre in South Gujarat. Adv Microbiol. 2017;  7(3):188-94. [Link]##Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2003; 2(2):114-22. [DOI:10.1038/nrd1008] [PMID]##Romling U, Balsalobre C. Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med. 2012; 272(6):541-61. [DOI:10.1111/joim.12004] [PMID]##Branda SS, González-Pastor JE, Ben-Yehuda S, Losick R, Kolter R. Fruiting body formation by Bacillus subtilis. Proc Natl Acad Sci U S A. 2001; 98(20):11621-6. [DOI:10.1073/pnas.191384198] [PMID]##Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999; 37(6):1771-6. [DOI:10.1128/JCM.37.6.1771-1776.1999] [PMID]##Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010; 35(4):322-32. [DOI:10.1016/j.ijantimicag.2009.12.011] [PMID]##Rice LB. Progress and challenges in implementing the research on ESKAPE pathogens. Infect Control Hosp Epidemiol. 2010; 31 (Suppl 1):S7-10. [DOI:10.1086/655995] [PMID]##Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002; 15(2):167-93. [DOI:10.1128/CMR.15.2.167-193.2002] [PMID]##Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science. 1999; 284(5418):1318-22. [DOI:10.1126/science.284.5418.1318] [PMID]##James GA, Swogger E, Wolcott R, Pulcini Ed, Secor P, Sestrich J, et al. Biofilms in chronic wounds. Wound Repair Regen. 2008; 16(1):37-44. [DOI:10.1111/j.1524-475X.2007.00321.x] [PMID]##Arduino JM, Kaye KS, Reed SD, Peter SA, Sexton DJ, Chen LF, et al. Staphylococcus aureus infections following knee and hip prosthesis insertion procedures. Antimicrob Resist Infect Control. 2015; 4:13. [DOI:10.1186/s13756-015-0057-4] [PMID]##Araby E, El-Tablawy SY. Inhibitory effects of rosemary (Rosemarinus officinalis L.) essential oil on pathogenicity of irradiated and non-irradiated Pseudomonas aeruginosa. J Photochem Photobiol B. 2016; 159:24-32. [DOI:10.1016/j.jphotobiol.2016.02.024] [PMID]##Kim YG, Lee JH, Kim SI, Baek KH, Lee J. Cinnamon bark oil and its components inhibit biofilm formation and toxin production. Int J Food Microbiol. 2015; 195:30-9. [DOI:10.1016/j.ijfoodmicro.2014.11.028] [PMID]##Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect. 2001; 109 Suppl 1(Suppl 1):69-75. [DOI:10.1289/ehp.01109s169] [PMID]##Masuku M, Mozirandi W, Mukanganyama S. Evaluation of the Antibacterial and Antibiofilm Effects of Ethyl Acetate Root Extracts from Vernonia adoensis (Asteraceae) against Pseudomonas aeruginosa. ScientificWorldJournal. 2023; 2023:5782656. [DOI:10.1155/2023/5782656] [PMID]##Mozirandi W, Mukanganyama S. Antibacterial Activity and Mode of Action of Vernonia adoensis (Asteraceae) Extracts against Staphylococcus aureus and Pseudomonas aeruginosa. J Biol Act Prod Nat. 2017; 7(5):341-57. [DOI:10.1080/22311866.2017.1378922]##Luo X, Jiang Y, Fronczek FR, Lin C, Izevbigie EB, Lee KS. Isolation and structure determination of a sesquiterpene lactone (vernodalinol) from Vernonia amygdalina extracts. Pharm Biol. 2011; 49(5):464-70. [DOI:10.3109/13880209.2010.523429] [PMID]##Abay SM, Lucantoni L, Dahiya N, Dori G, Dembo EG, Esposito F, et al. Plasmodium transmission blocking activities of Vernonia amygdalina extracts and isolated compounds. Malar J. 2015; 14:288. [PMID]##Mozirandi W, Tagwireyi D, Mukanganyama S. Evaluation of antimicrobial activity of chondrillasterol isolated from Vernonia adoensis (Asteraceae). BMC Complement Altern Med. 2019; 19(1):249. [DOI:10.1186/s12906-019-2657-7] [PMID]##Swamy TA, Obey J, Mutuku NC. Phytochemical analysis of Vernonia adoensis leaves and roots used as a traditional medicinal plants in Kenya. Int J Pharm Biol Sci. 2013; 3(3):46-52. [Link]##Gull J, Sultana B, Anwar F, Naseer R, Ashraf M, Ashrafuzzaman M. Variation in antioxidant attributes at three ripening stages of guava (Psidium guajava L.) fruit from different geographical regions of Pakistan. Molecules. 2012; 17(3):3165-80. [DOI:10.3390/molecules17033165] [PMID]##Mphahlele RR, Stander MA, Fawole OA, Opara UL. Effect of fruit maturity and growing location on the postharvest contents of flavonoids, phenolic acids, vitamin C and antioxidant activity of pomegranate juice (cv. Wonderful). Sci Hortic (Amsterdam). 2014; 179:36-45. [DOI:10.1016/j.scienta.2014.09.007]##Okeke MI, Iroegbu CU, Eze EN, Okoli AS, Esimone CO. Evaluation of extracts of the root of Landolphia owerrience for antibacterial activity. J Ethnopharmacol. 2001; 78(2-3):119-27. [DOI:10.1016/S0378-8741(01)00307-5] [PMID]##Broschat SL, Call DR, Kuhn EA, Loge FJ. Comparison of the reflectance and crystal violet assays for measurement of bioflm formation by Enterococcus.  Biofilms. 2005; 2(3):177-81. [Link]##Chaieb K, Kouidhi B, Jrah H, Mahdouani K, Bakhrouf A. Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complement Altern Med. 2011; 11:29.[DOI:10.1186/1472-6882-11-29] [PMID]##Ramage G, López-Ribot JL. Techniques for antifungal susceptibility testing of Candida albicans biofilms. Methods Mol Med. 2005; 118:71-9.  [DOI:10.1385/1-59259-943-5:071] [PMID]##Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998; 280(5361):295-8. [DOI:10.1126/science.280.5361.295] [PMID]##Ekow Thomford N, Dzobo K, Adu F, Chirikure S, Wonkam A, Dandara C. Bush mint (Hyptis suaveolens) and spreading hogweed (Boerhavia diffusa) medicinal plant extracts differentially affect activities of CYP1A2, CYP2D6 and CYP3A4 enzymes. J Ethnopharmacol. 2018; 211:58-69. [DOI:10.1016/j.jep.2017.09.023] [PMID]##Akiyama K, Chikayama E, Yuasa H, Shimada Y, Tohge T, Shinozaki K, et al. PRIMe: A Web site that assembles tools for metabolomics and transcriptomics. In Silico Biol. 2008; 8(3-4):339-45.  [PMID]##Moco S, Bino RJ, Vorst O, Verhoeven HA, de Groot J, van Beek TA, et al. A liquid chromatography-mass spectrometry-based metabolome database for tomato. Plant Physiol. 2006; 141(4):1205-18. [DOI:10.1104/pp.106.078428] [PMID]##Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu Rev Microbiol. 2002; 56:187-209.  [DOI:10.1146/annurev.micro.56.012302.160705] [PMID]##Clatworthy AE, Pierson E, Hung DT. Targeting virulence: A new paradigm for antimicrobial therapy. Nat Chem Biol. 2007; 3(9):541-8.  [DOI:10.1038/nchembio.2007.24] [PMID]##Davies DG, Marques CN. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol. 2009; 191(5):1393-403. [DOI:10.1128/JB.01214-08] [PMID]##Kumar PP, Kumaravel S, Lalitha C. Screening of antioxidant activity, total phenolics and GC-MS study of Vitex negundo. African J Biochem Res. 2009; 4:191-5. [Link]##Jancy Rani PM, Kannan P, Kumaravel S. Screening of antioxidant activity, total phenolics and gas chromatograph and mass spectrometer (GC-MS) study of Delonix regia. Afr J Biochem Res. 2011; 5(12):341-7. [Link]##Costa DC, Costa HS, Albuquerque TG, Ramos F, Castilho MC, Sanches-Silva A. Advances in phenolic compounds analysis of aromatic plants and their potential applications. Trends  Food Sci Technol. 2015; 45(2):336-54. [DOI:10.1016/j.tifs.2015.06.009]##Kampkötter A, Gombitang Nkwonkam C, Zurawski RF, Timpel C, Chovolou Y, Wätjen W, et al. Effects of the flavonoids kaempferol and fisetin on thermotolerance, oxidative stress and FoxO transcription factor DAF-16 in the model organism Caenorhabditis elegans. Arch Toxicol. 2007; 81(12):849-58.  [DOI:10.1007/s00204-007-0215-4] [PMID]##Al-Numair KS, Chandramohan G, Veeramani C, Alsaif MA. Ameliorative effect of kaempferol, a flavonoid, on oxidative stress in streptozotocin-induced diabetic rats. Redox Rep. 2015; 20(5):198-209. [DOI:10.1179/1351000214Y.0000000117] [PMID]##Park MJ, Lee EK, Heo HS, Kim MS, Sung B, Kim MK, et al. The anti-inflammatory effect of kaempferol in aged kidney tissues: the involvement of nuclear factor-kappaB via nuclear factor-inducing kinase/IkappaB kinase and mitogen-activated protein kinase pathways. J Med Food. 2009; 12(2):351-8. [DOI:10.1089/jmf.2008.0006] [PMID]##Nguyen TT, Tran E, Ong CK, Lee SK, Do PT, Huynh TT, et al. Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK. J Cell Physiol. 2003; 197(1):110-21. [DOI:10.1002/jcp.10340] [PMID]##Abu-Reidah IM, Ali-Shtayeh MS, Jamous RM, Arraez-Roman D, Segura-Carretero A. Comprehensive metabolite profiling of Arum palaestinum (Araceae) leaves by using liquid chromatography–tandem mass spectrometry. Food Res Int. 2015; 70:74-86. [DOI:10.1016/j.foodres.2015.01.023]##Ozçelik B, Kartal M, Orhan I. Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids. Pharm Biol. 2011; 49(4):396-402. [DOI:10.3109/13880209.2010.519390] [PMID]##Hossan S, Rahman S, Bashar ABMA, Jahan R. Rosmarinic acid : A review of its anticancer action. World J Phamarcy Pharm Sci. 2014; 3:57-70. [Link]##Murtaza G, Sajjad A, Mehmood Z, Shah SH, Siddiqi AR. Possible molecular targets for therapeutic applications of caffeic acid phenethyl ester in inflammation and cancer. J Food Drug Anal. 2015; 23(1):11-18.  [DOI:10.1016/j.jfda.2014.06.001] [PMID]##Husain SR, Cilurd J, Cillard P. Hydroxyl radical scavenging activity of flavonoids. Phytochemistry. 1987; 26(9):2489-91.[DOI:10.1016/S0031-9422(00)83860-1]##Jnawali HN, Lee E, Jeong KW, Shin A, Heo YS, Kim Y. Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK. J Nat Prod. 2014; 77(2):258-63. [DOI:10.1021/np400803n] [PMID]##Dirscherl K, Karlstetter M, Ebert S, Kraus D, Hlawatsch J, Walczak Y, et al. Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. J Neuroinflammation. 2010; 7:3. [DOI:10.1186/1742-2094-7-3] [PMID]##Byun S, Lee KW, Jung SK, Lee EJ, Hwang MK, Lim SH, et al. Luteolin inhibits protein kinase C(epsilon) and c-Src activities and UVB-induced skin cancer. Cancer Res. 2010; 70(6):2415-23. [DOI:10.1158/0008-5472.CAN-09-4093] [PMID]##Wollenweber E. Flavonoid excretion in betula species. Biochem Physiol Pflanz. 1974; 166(5):425-8. [Link]##Lou Z, Wang H, Zhu S, Zhang M, Gao Y, Ma C, et al. Improved extraction and identification by ultra performance liquid chromatography tandem mass spectrometry of phenolic compounds in burdock leaves. J Chromatogr A. 2010; 1217(16):2441-6. [DOI:10.1016/j.chroma.2009.12.022] [PMID]##Liang YZ, Xie P, Chan K. Quality control of herbal medicines. J Chromatogr B Analyt Technol Biomed Life Sci. 2004; 812(1-2):53-70. [DOI:10.1016/j.jchromb.2004.08.041] [PMID]##Nikam PH, Kareparamban J, Jadhav A, Kadam V. Future trends in standardization of herbal drugs. J Appl Pharm Sci. 2012; 2(6):38-44. [Link]## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Pharmacological Assessment of Indigofera hochstetteri: Anti-inflammatory and Analgesic Potential</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Inflammation and pain are essential physiological responses that protect the body against harmful stimuli. However, when chronic, they can result in severe health problems and disability. The available treatment options have significant limitations, necessitating the search for safer alternatives.&#160;
Objectives: This study aimed to evaluate the anti-inflammatory and analgesic potential of the methanol leaf extract of Indigofera hochstetteri.
Methods: The methanol extract of I. hochstetteri was subjected to phytochemical screening and acute toxicity assessment using Lorke&#8217;s method. Anti-inflammatory activity was examined using formalin-induced paw edema and xylene-induced ear edema, while acetic acid-induced writhing and hot plate tests were employed to assess analgesic activity.
Results: Phytochemical analysis indicated the presence of flavonoids, glycosides, terpenes, and saponins. Acute toxicity studies indicated a moderate toxicity level, with a median lethal dose of 2,154 mg/kg. The extract displayed statistically significant (P&#60;0.05) anti-inflammatory effects in both the formalin and xylene models. Substantial analgesic activity was also observed in both the writhing and hot plate tests. The extract&#8217;s efficacy was directly proportional to the dose, with higher doses (300 and 600 mg/kg) showing effectiveness similar to that of standard drugs.
Conclusion: These findings imply that I. hochstetteri has promising potential as a natural alternative for managing inflammation and pain.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>227</FPAGE>
			<TPAGE>236</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2025/07/122025/01/252025/02/172023/06/82025/01/21
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1403/11/2
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2025/09/212025/07/192025/08/162025/04/262025/07/19
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1404/4/28
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Albashir</Name>
				<MidName></MidName>
				<Family>Tahir</Family>
				<NameE>Albashir</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Tahir</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Faculty of Basic Medical Sciences, Bauchi State University, Gadau, Nigeria.</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>albashirtahir@basug.edu.ng</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Khadija Abdullahi</Name>
				<MidName></MidName>
				<Family>Kobi</Family>
				<NameE>Khadija Abdullahi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kobi</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Faculty of Basic Medical Sciences, Bauchi State University, Gadau, Nigeria.</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>khadijahkobee@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Musab Abba</Name>
				<MidName></MidName>
				<Family>Usman</Family>
				<NameE>Musab Abba</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Usman</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Faculty of Basic Medical Sciences, Bauchi State University, Gadau, Nigeria.</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>abbamusab7@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Nura</Name>
				<MidName></MidName>
				<Family>Abubakar</Family>
				<NameE>Nura</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Abubakar</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Therapeutics, Faculty of Basic Clinical Sciences, College of Health Sciences, Usmanu Danfodiyo University, Sokoto 840001, Nigeria</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>nuradosara@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Suleiman</Name>
				<MidName></MidName>
				<Family>Yunusa</Family>
				<NameE>Suleiman</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Yunusa</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology and Therapeutics, Faculty of Basic Clinical Sciences, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria.</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>syunusa@basug.edu.ng</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Indigofera hochstetteri</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Ethnomedicine</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Medicinal plants</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Anti-inflammatory</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Analgesic</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Stretanski MF, Kopitnik NL, Matha A, Conermann T. Chronic pain. [Updated 2025 Jun 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: [Link]##Pahwa R, Goyal A, Jialal I. Chronic inflammation. 2023 Aug 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. [PMID]##Saad J, Mathew D. Nonsteroidal anti-inflammatory drugs toxicity. 2025 Sep 15. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. [PMID]##Crockett SD, Greer KB, Heidelbaugh JJ, Falck-Ytter Y, Hanson BJ, Sultan S, et al. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation. Gastroenterology. 2019; 156(1):218-26. [DOI:10.1053/j.gastro.2018.07.016] [PMID]##Cohen B, Ruth LJ, Preuss CV. Opioid Analgesics. 2023 Apr 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. [PMID]##Hodgens A, Sharman T. Corticosteroids. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. [PMID]##Mensah MLK, Komlaga G, Forkuo A, Firempong C, Anning A, Dickson RA. Toxicity and Safety Implications of Herbal Medicines Used in Africa. In: Builders P, editor. Herbal Medicine. London: IntechOpen; 2019. [DOI:10.5772/intechopen.72437]##Christenhusz MJM, Byng JW. The number of known plants species in the world and its annual increase. Phytotaxa. 2016; 261:201-17. [DOI:10.11646/phytotaxa.261.3.1]##Govaerts R. World checklist of vascular plants (WCVP) -version 12. Melbourne: Royal Botanic Gardens, Kew Research Repository; 2023. [Link]##Open Herbarium. Indigofera hochstetter. [Internet]. 2024 [Updated 2024 May 25]. Available from: [Link]##Gerometta E, Grondin I, Smadja J, Frederich M, Gauvin-Bialecki A. A review of traditional uses, phytochemistry and pharmacology of the genus Indigofera. J Ethnopharmacol. 2020; 253:112608. [DOI:10.1016/j.jep.2020.112608] [PMID]##Prabhu N, Harshini D, Gowsalya A, Rekha J, Rajamehala M, Karthick PJ, et al. Evaluation of Genoprotective Activity of Indigofera tinctoria using Allium cepa Root. J Pharm Res Int. 2021; 33(60B):2958-72. [DOI:10.9734/jpri/2021/v33i60B34965]##Haider MS, Imran I. Pharmacological investigation of activities pertaining to modulation of gastrointestinal, respiratory and cardiovascular parameters by Indigofera argentea in experimental models. Pak J Pharm Sci. 2020; 33(5(Supplementary)):2257-67. [PMID]##Rakwa EE, Koubala BB, Mando BN, Djongra M, Nveikoueing F, Ndjonka D. Antifilarial Activity of the Methanolic Extract of Indigofera tinctoria (Fabaceae) on Bovine Parasites (Onchocerca ochengi). J Parasitol Res. 2022; 2022:7828551. [DOI:10.1155/2022/7828551] [PMID]##Bhat SA, Zargar MI, Wani SUD, Mohiuddin I, Masoodi MH, Shakeel F, et al. In-vitro evaluation of Indigofera heterantha extracts for antibacterial, antifungal and anthelmintic activities. J Pharm Health Care Sci. 2024; ;10(1):7. [DOI:10.1186/s40780-024-00328-y] [PMID]##Evans WC, Trease GE, Evans D. Trease and Evans’ pharmacognosy. Edinburgh ; New York: WB Saunders; 2002. [Link]##Lorke D. A new approach to practical acute toxicity testing. Arch Toxicol. 1983; 54:275–87. [DOI:10.1007/BF01234480]##Eddouks M, Chattopadhyay D, Zeggwagh NA. Animal models as tools to investigate antidiabetic and anti-inflammatory plants. Evid Based Complement Alternat Med. 2012; 2012:142087. [DOI:10.1155/2012/142087] [PMID]##Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol. 2002; 2:7. [PMID]##Eddy NB, Leimbach D. Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J Pharmacol Exp Ther. 1953; 107(3):385-93. [DOI:10.1016/S0022-3565(25)05180-8]##Atta E, Al faifi T, El-Shabasy A. Chemotaxonomic and morphological classification of six Indigofera species in Jazan region, KSA. J Saudi Chem Soc. 2022; 26(3):101476. [10.1016/j.jscs.2022.101476]##Hodge HC, Sterner JH. Tabulation of toxicity classes. Am Ind Hyg Assoc Q. 1949; 10(4):93-6. [DOI:10.1080/00968204909344159] [PMID]##Wheeler-Aceto H, Cowan A. Neurogenic and tissue-mediated components of formalin-induced edema: Evidence for supraspinal regulation. Agents Actions. 1991; 34(1-2):264-9. [DOI:10.1007/BF01993299] [PMID]##Damas J, Liégeois JF. The inflammatory reaction induced by formalin in the rat paw. Naunyn Schmiedebergs Arch Pharmacol. 1999; 359(3):220-7. [DOI:10.1007/pl00005345] [PMID]##McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, Zhao M, Hayward NJ, et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A. 2007; (33):13525-30. [DOI:10.1073/pnas.0705924104] [PMID]##Soliman SM, Teaima MH, Rashwan KO, Ali BM, Jasti BR, El-Nabarawi MA, et al. The deleterious effect of xylene-induced ear edema in rats: Protective role of dexketoprofen trometamol transdermal invasomes via inhibiting the oxidative stress/NF-κB/COX-2 pathway. Int J Pharm. 2023; 631:122525. [DOI:10.1016/j.ijpharm.2022.122525] [PMID]##Al-Khayri JM, Sahana GR, Nagella P, Joseph BV, Alessa FM, Al-Mssallem MQ. Flavonoids as potential anti-inflammatory molecules: A review. Molecules. 2022; 27(9):2901. [DOI:10.3390/molecules27092901] [PMID]##Ahmadi M, Bekeschus S, Weltmann KD, von Woedtke T, Wende K. Non-steroidal anti-inflammatory drugs: Recent advances in the use of synthetic COX-2 inhibitors. RSC Med Chem. 2022; 13(5):471-96. [DOI:10.1039/d1md00280e] [PMID]##Ju Z, Li M, Xu J, Howell DC, Li Z, Chen FE. Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years. Acta Pharm Sin B. 2022 ; 12(6):2790-807. [DOI:10.1016/j.apsb.2022.01.002] [PMID]##Del Prado-Audelo ML, Cortés H, Caballero-Florán IH, González-Torres M, Escutia-Guadarrama L, Bernal-Chávez SA, et al. Therapeutic Applications of Terpenes on Inflammatory Diseases. Front Pharmacol. 2021; 12:704197. [DOI:10.3389/fphar.2021.704197] [PMID]##Prakash V. Terpenoids as Source of Anti-inflammatory Compounds. Asian J Pharm Clin Res 2017; 10(3):68-76. [DOI:10.22159/ajpcr.2017.v10i3.16435.]##Souza MT, Almeida JR, Araujo AA, Duarte MC, Gelain DP, Moreira JC, et al. Structure–activity relationship of terpenes with anti-inflammatory profile – a systematic review. Basic Clin Pharmacol Toxicol. 2014; (3):244-56. [DOI:10.1111/bcpt.12221] [PMID]##Wijesekara T, Luo J, Xu B. Critical review on anti-inflammation effects of saponins and their molecular mechanisms. Phytother Res. 2024; 38(4):2007-22. [DOI:10.1002/ptr.8164] [PMID]##Fürst R, Zündorf I, Dingermann T. New Knowledge About Old Drugs: The Anti-Inflammatory Properties of Cardiac Glycosides. Planta Med. 2017; 83(12-13):977-84.  [DOI:10.1055/s-0043-105390] [PMID]##Zhang D, Liu R, Sun L, Huang C, Wang C, Zhang DM, et al. Anti-Inflammatory Activity of Methyl Salicylate Glycosides Isolated from Gaultheria yunnanensis (Franch.) Rehder. Molecules. 2011; 16(5):3875-84.  [DOI:10.3390/molecules16053875] [PMID] ##Avunduk S. Chapter 7 - Antiinflammatory saponins. In: Atta-Ur-Rahman, editor. Studies in Natural Products Chemistry. Amsterdam: Elsevier; 2024. [Link]##Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011; 31(5):986-1000.  [DOI:10.1161/ATVBAHA.110.207449] [PMID] ##Gawade SP. Acetic acid induced painful endogenous infliction in writhing test on mice. J Pharmacol Pharmacother. 2012; 3(4):348.  [DOI:10.4103/0976-500X.103699] [PMID]##Abubakar H, Tahir A, Umar A. Boswellia dalzielii Methanol Stem Bark Extract Demonstrates Significant Analgesic Activity in Swiss Albino Mice. Sci Phytochem. 2024; 3(1):38-43.  [DOI:10.58920/sciphy0301225]##Ferraz CR, Carvalho TT, Manchope MF, Artero NA, Rasquel-Oliveira FS, Fattori V, et al. Therapeutic Potential of Flavonoids in Pain and Inflammation: Mechanisms of Action, Pre-Clinical and Clinical Data, and Pharmaceutical Development. Molecules. 2020; 25(3):762. [DOI:10.3390/molecules25030762] [PMID]##Zheng Y, Yin X, Huo F, Xiong H, Mei Z. Analgesic effects and possible mechanisms of iridoid glycosides from Lamiophlomis rotata (Benth.) Kudo in rats with spared nerve injury. J Ethnopharmacol. 2015; 173:204-11. [DOI:10.1016/j.jep.2015.06.045] [PMID]##Chindo B, Anuka J, Isaac E, Ahmadu A, Tarfa F, Gamaniel K. Saponins are involved in the analgesic and anti-inflammatory properties of Ficus platyphylla stem bark. Int J Biol Chem Sci. 2010; 4(2). [DOI:10.4314/ijbcs.v4i2.58140]##Xiao X, Wang X, Gui X, Chen L, Huang B. Natural Flavonoids as Promising Analgesic Candidates: A Systematic Review. Chem Biodivers. 2016; 13(11):1427-40. [DOI:10.1002/cbdv.201600060] [PMID]##Khan H, Pervaiz A, Intagliata S, Das N, Nagulapalli Venkata KC, Atanasov AG, et al. The analgesic potential of glycosides derived from medicinal plants. DARU. 2020; 28(1):387-401.   [DOI:10.1007/s40199-019-00319-7] [PMID]## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Clinical and Prognostic Findings in Psychotropic Substance Poisoning: A Cross-sectional Study</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Psychotropic substance poisoning is a growing public health concern.&#160;
Objectives: This study aimed to investigate patients with psychedelic poisoning and evaluate the frequency of clinical, preclinical, and prognostic findings.
Methods: This retrospective cross-sectional study extracted clinical findings of patients, including neurological findings, cardiovascular findings, preclinical findings, treatment measures, and prognosis of patients poisoned with psychoactive substances who were admitted to Shah Vali Hospital in Yazd Province, Iran, and Shaheed Beheshti Hospital in Taft City, Iran, from 2014 to 2023 from their medical records and the hospital information system (HIS).
Results: In the present study, information was extracted from 311 patients with psychotropic intoxication, comprising 164 individuals who had used stimulants and 147 who had used hallucinogens. The highest frequency of stimulant use was related to glass, with 160 individuals (51.4%), and the highest frequency of hallucinogen use was related to hashish, with 138 individuals (44.4%). Notably, most patients survived (99.67%). The most common symptoms observed were increased blood pressure (BP) (28.2%), mydriasis (73.31%), tachycardia (77.9%), shock (1.9%), seizures (5.5%), and agitation (68.16%). Elevated creatine phosphokinase (CPK) levels were observed in 3.53% of patients, and the severity of intoxication was statistically significant (P=0.001). The results also showed a significant difference in the frequency distribution of psychoactive substances (stimulants and hallucinogens) according to the route of consumption (oral vs inhalation). Specifically, most psychoactive substances (both stimulants and hallucinogens) were inhaled rather than ingested (P&#60;0.01). Also, a significant difference was observed in the frequency distribution of individuals poisoned with psychedelics (stimulants and hallucinogens) according to the reason for consumption (suicide vs abuse) (P&#62;0.01). In this regard, the most common reason for consumption was abuse (70.1%). The frequency distribution of treatment types among patients poisoned with psychotropic drugs (stimulants and hallucinogens) showed that benzodiazepines were the most frequently used treatment (73%).
Conclusion: This study of 311 patients with psychedelic poisoning reveals a significant prevalence of substance abuse, particularly among younger males, with stimulants being the most commonly used drugs. These findings underscore the urgent need for targeted prevention and intervention programs to address the critical issue of psychotropic substance misuse among at-risk populations.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>237</FPAGE>
			<TPAGE>250</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2025/07/122025/01/252025/02/172023/06/82025/01/212024/11/14
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1403/8/24
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2025/09/212025/07/192025/08/162025/04/262025/07/192025/08/16
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1404/5/25
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Hanieh</Name>
				<MidName></MidName>
				<Family>Hatampour</Family>
				<NameE>Hanieh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hatampour</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>hatamporh1995@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hamid Reza</Name>
				<MidName></MidName>
				<Family>Jamshidi</Family>
				<NameE>Hamid Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Jamshidi</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>hrz.jamshidi@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Komeil</Name>
				<MidName></MidName>
				<Family>Aghazadeh-Habashi</Family>
				<NameE>Komeil</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Aghazadeh-Habashi</FamilyE>
				<Organizations>
				<Organization>Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>komeil.aghazade@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Sareh</Name>
				<MidName></MidName>
				<Family>Rafatmagham</Family>
				<NameE>Sareh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rafatmagham</FamilyE>
				<Organizations>
				<Organization>Department of Internal Medicine, Fasa University of Medical Sciences, Fasa, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Niloofarderavi@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Farhad</Name>
				<MidName></MidName>
				<Family>Farnaghi</Family>
				<NameE>Farhad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Farnaghi</FamilyE>
				<Organizations>
				<Organization>Department of Psychiatry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>drfarhadfarnaghi@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hamidreza</Name>
				<MidName></MidName>
				<Family>Ghasemirad</Family>
				<NameE>Hamidreza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghasemirad</FamilyE>
				<Organizations>
				<Organization>Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>hr.ghasemirad@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mehrnoush</Name>
				<MidName></MidName>
				<Family>Giahi Yazdi</Family>
				<NameE>Mehrnoush</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Giahi Yazdi</FamilyE>
				<Organizations>
				<Organization>Social Security Organization of Yazd, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mehrnoushg.yazdi@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohsen</Name>
				<MidName></MidName>
				<Family>Jabari</Family>
				<NameE>Mohsen</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Jabari</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Mo.jabbari75@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Khashayar</Name>
				<MidName></MidName>
				<Family>Moravej</Family>
				<NameE>Khashayar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Moravej</FamilyE>
				<Organizations>
				<Organization>Faculty of Dentistry, Isfahan Branch, Islamic Azad University, Isfahan, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Khashayarmoravej@hotmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hamid</Name>
				<MidName></MidName>
				<Family>Owliaey</Family>
				<NameE>Hamid</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Owliaey</FamilyE>
				<Organizations>
				<Organization>Department of Forensic Medicine &#38; Clinical Toxicology, Yazd Branch, Islamic Azad University, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>hamid.owliaey@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Psychedelic poisoning</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Glass</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hashish</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Stimulants</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hallucinogens</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Hadinezhad P, Zarghami M, Montazer H, Moosazadeh M, Ghaderi F. Study of methamphetamine use in patients referred to emergency ward of a general Hospital at North of Iran in 2017. Addict Health. 2019; 11(1):18-25. [PMID]##Oyesanmi O, Kunkel EJ, Monti DA, Field HL. Hematologic side effects of psychotropics. Psychosomatics. 1999; 40(5):414-21. [DOI:10.1016/S0033-3182(99)71206-5] [PMID]##Shekari H, Eftekhari A. [Association between psychotropic drug usage and crime in central prison of Urmia, Iran (Persian)]. Iran J Forensic Med. 2015; 20(4):187-92. [Link]##Giugovaz A, Grassi M, Marchetti I. Substance addictions and suicidal thoughts and behaviors: Evidence from a multi-wave epidemiological study. Psychiatry Res. 2024; 334:115821. [DOI: 10.1016/j.psychres.2024.115821] [PMID]##Shafi A, Berry AJ, Sumnall H, Wood DM, Tracy DK. New psychoactive substances: A review and updates. Ther Adv Psychopharmacol. 2020; 10:2045125320967197. [DOI:10.1177/2045125320967197] [PMID]##Jahangard L, Haghighi M, Mahmoudi Akhzar K, Seifrabei M, Ahmadpanah M, Mousavi L, et al. [Evaluating Amphetamine and methamphetamine abuse frequency in hospitalized patients of the psychiatric ward of Farshchian Hospital in Hamadan city (Persian)]. Avicenna J Clin Med. 2017; 24(1):80-6. [DOI:10.21859/hums-240111]##Goudarzi F, Ansari H, Gholamzadeh S, Zarenezhad M, Maleki M, Jafarizadeh F, et al. [Evaluation of the frequency, clinical signs &#38; prognosis of drug abuse in poisoning cases referred to Shiraz Shoushtari Hospital from September 2008 to September 2010 (Persian)]. Iran J Forensic Med. 2016; 22(1):7-14.##Alter D, Beverley JA, Patel R, Bolaños-Guzmán CA, Steiner H. The 5-HT1B serotonin receptor regulates methylphenidate-induced gene expression in the striatum: Differential effects on immediate-early genes. J Psychopharmacol. 2017; 31(8):1078-87. [DOI:10.1177/0269881117715598] [PMID]##Izadi-Mood N, Tavahen N, Masoumi GR, Gheshlaghi F, Dana Siadat Z, Setareh M, et al. Demographic factors, duration of hospitalization, costs of hospitalization, and cause of death in patients intoxicated with amphetamines and opioids. J Isfahan Med Sch. 2011; 29(146):890-900. [Link]##Schuerer S, Klingel K, Sandri M, Majunke N, Besler C, Kandolf R, et al. Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy. JACC Heart Fail. 2017; 5(6):435-45.[DOI:10.1016/j.jchf.2017.02.017] [PMID]##Müller D, Weinmann W, Hermanns-Clausen M. Chinese slimming capsules containing sibutramine sold over the Internet: A case series. Dtsch Arztebl Int. 2009; 106(13):218-22. [DOI:10.3238/arztebl.2009.0218] [PMID]##Ataee M, Hosseini SN, Jouybari TA, Jalilian F, Alavijeh MM, Eslami AA, et al. [Application of prototype/willingness model in describe ritalin abuse behavior among college students (Persian)]. J Health Syst Res. 2014; 10(2):335-44. [Link]##Katebi ŸR, Katebi Y, Shabani R, Alizadeh A, Rafiee M, Soleimani M. Ritalin abuse and its complications. J Isfahan Med Sch. 2017; 35(420):170-6. [Link]##Parsa F, Hosseini S, Mehrabani D, Hashemi S. [The effect of cannabis extract on SH-SY5Y nerve cell (Persian)]. J Ardabil Univ Med Sci. 2020; 20(2):232-41. [DOI:10.52547/jarums.20.2.232]##Bouziri A, Hamdi A, Borgi A, Hadj SB, Fitouri Z, Menif K, et al. Datura stramonium L. poisoning in a geophagous child: A case report. Int J Emerg Med. 2011; 4(1):31. [DOI:10.1186/1865-1380-4-31] [PMID]##De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, et al. Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine. J Neurosci. 2021; 41(5):891-900. [DOI:10.1523/JNEUROSCI.1659-20.2020] [PMID]##Darke S, Duflou J, Lappin J, Kaye S. Clinical and autopsy characteristics of fatal methamphetamine toxicity in Australia. J Forensic Sci. 2018; 63(5):1466-71. [DOI:10.1111/1556-4029.13710] [PMID]##Holze F, Vizeli P, Müller F, Ley L, Duerig R, Varghese N, et al. Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects. Neuropsychopharmacology. 2020; 45(3):462-71. [DOI:10.1038/s41386-019-0569-3] [PMID]##Liechti ME. Modern clinical research on LSD. Neuropsychopharmacology. 2017; 42(11):2114-27. [DOI:10.1038/npp.2017.86] [PMID]##Aria A, Pourbadakhshan N, Alizadeh A. Evaluation of the clinical and paraclinical symptoms of children intoxicated with amphetamines in Akbar Hospital of Mashhad, Iran 2021-2022. Pediatr Emerg Care. 2024; 40(11):766-9.[DOI:10.1097/PEC.0000000000003234] [PMID]##Dorooshi G, Borhani A, Zoofaghari S, Tarrahi MJ, Meamar R, Samsam Shariat S. Risk factors for opioids and stimulants poisoning among patients admitted to Khorshid Hospital in Isfahan. J Isfahan Med Sch. 2022; 40(676):435-42. [Link]##Farzaneh E, Bashkooh Y, Amani F, Nasl-Seraji F, Mehrpoor O. Evaluation of the frequency of stimulant and opioid abuse in the poisoned cases referred To Hospitals in Ardabil, Iran. J Patient Saf  Qual Improv. 2021; 9(3):177-82. [DOI:10.22038/psj.2021.57184.1320]##Zarifhoshiar J, Roostami Nejad M, Aivazi Aa. [Evaluation of the clinical signs, paraclinical findings and between 2010 and 2011 referred to Loghman Hakim Hospital Out Comes of Amphetamins Poisning in Children (Persian)]. J Ilam Uni Med Sci. 2013; 21(1):123-8. [Link]##Masoumi G, Eizadi-Mood N, Akabri M, Sohrabi A, Khalili Y. [Pattern of Poisoning in Isfahan (Persian)]. J Isfahan Med Sch. 2011; 29(163):1317-24. [Link]##Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults. JAMA Psychiatry. 2021; 78(12):1329-42. [DOI:10.1001/jamapsychiatry.2021.2588] [PMID]##Hassanian-Moghaddam H, Ranjbar M, Farnaghi F, Zamani N, Alizadeh AM, Sarjami S. Stimulant Toxicity in Children: A retrospective study on 147 patients. Pediatr Crit Care Med. 2015; 16(8):e290-6. [DOI:10.1097/PCC.0000000000000506] [PMID]##Chen T, Spiller HA, Badeti J, Funk AR, Zhu M, Smith GA. Methamphetamine exposures reported to United States poison control centers, 2000-2019. Clin Toxicol (Phila). 2021; 59(8):705-14. [DOI:10.1080/15563650.2020.1861287] [PMID]##Ruha AM, Yarema MC. Pharmacologic treatment of acute pediatric methamphetamine toxicity. Pediatr Emerg Care. 2006; 22(12):782-5. [DOI:10.1097/01.pec.0000245179.51535.ab] [PMID]## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Structure-based In-silico Screening Reveals Promising Repurposed Drugs for Targeting Monkeypox Virus Proteins</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Monkeypox (mpox) has re-emerged as a significant global health concern, with outbreaks prompting public health emergencies. Despite the availability of vaccines and a few non-specific antivirals, no targeted therapy has been approved for pox, underscoring the urgent need for novel treatment strategies.&#160;
Objectives: This study aimed to identify potential high-affinity drug candidates against mpox by repurposing existing compounds using structure-based molecular docking. It focused on five essential viral proteins involved in the virus&#8217;s replication and pathogenesis.
Methods: Five mpox viral proteins&#8212;A48R (thymidylate kinase), A50R (DNA ligase), D13L (capsid protein), F13L (envelope protein), and I7L (cysteine protease)&#8212;were modeled using AlphaFold2 and prepared using Chimera and PyRx software. Over 300 compounds with known antiviral activity were screened using molecular docking with AutoDock Vina. The binding energies and protein-ligand interactions were analyzed using PyMOL and Discovery Studio. Top candidates were selected based on binding affinity, pharmacokinetics, and safety profiles.
Results: Several repurposed drugs demonstrated superior binding affinities compared to known inhibitors. Notably, baicalin (-10.0 kcal/mol) for A48R, ledipasvir (-10.3 kcal/mol) for A50R and I7L, and suramin (-13.2 and -10.7 kcal/mol) for D13L and F13L outperformed reference compounds. These drugs also exhibited favorable pharmacokinetic properties and established safety profiles.
Conclusion: This in silico drug repurposing approach highlights promising candidates for further investigation of mpox. The findings offer a foundation for experimental validation and support accelerated therapeutic development for emerging poxvirus threats.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>251</FPAGE>
			<TPAGE>260</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2025/07/122025/01/252025/02/172023/06/82025/01/212024/11/142025/04/16
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1404/1/27
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2025/09/212025/07/192025/08/162025/04/262025/07/192025/08/162025/09/30
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1404/7/8
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Mahdi</Name>
				<MidName></MidName>
				<Family>Amirzadeh</Family>
				<NameE>Mahdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Amirzadeh</FamilyE>
				<Organizations>
				<Organization>Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mahdiamirzadeh@sbmu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ali</Name>
				<MidName></MidName>
				<Family>Jabbarzadeh</Family>
				<NameE>Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Jabbarzadeh</FamilyE>
				<Organizations>
				<Organization>Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Alijabbarzadeh@sbmu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Shahed</Name>
				<MidName></MidName>
				<Family>Ahmadi</Family>
				<NameE>Shahed</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ahmadi</FamilyE>
				<Organizations>
				<Organization>Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>shahedahmadi@sbmu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mehraveh</Name>
				<MidName></MidName>
				<Family>Ahmadi</Family>
				<NameE>Mehraveh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ahmadi</FamilyE>
				<Organizations>
				<Organization>Institute for Cognitive Science Studies, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Mehraveh.ahmadi@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mousa</Name>
				<MidName></MidName>
				<Family>Ahmadi</Family>
				<NameE>Mousa</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ahmadi</FamilyE>
				<Organizations>
				<Organization>Department of Infectious Disease, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mousa.ahmadi1344@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Monkeypox (mpox)</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Treatment</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Vaccine</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>In silico</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Drug repurposing</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>WHO. WHO Director-General declares mpox outbreak a public health emergency of international concern. Geneva: WHO; 2024. [Link]##Li K, Yuan Y, Jiang L, Liu Y, Liu Y, Zhang L. Animal host range of mpox virus. J Med Virol. 2023; 95(2):e28513. [DOI:10.1002/jmv.28513] [PMID]##Naseer MM, Afzal M, Fatima T, Nabiha, Rafique H, Munir A. Human monkeypox virus: A review on the globally emerging virus. Biomed Lett. 2024; 10(1):26-41. [DOI:10.47262/BL/10.1.20242161]##Yon H, Shin H, Shin JI, Shin JU, Shin YH, Lee J, et al. Clinical manifestations of human monkeypox infection: A systematic review and meta-analysis. Rev Med Virol. 2023; 33(4):e2446. [DOI:10.1002/rmv.2446] [PMID]##Correia C, Alpalhão M, de Sousa D, Vieitez-Frade J, Pelerito A, Cordeiro R, et al. Detection of mpox using polymerase chain reaction from the skin and oropharynx over the course of infection: A prospective study. J Am Acad Dermatol. 2023; 89(4):822-3.[DOI:10.1016/j.jaad.2023.05.071] [PMID]##Rao AK, Schrodt CA, Minhaj FS, Waltenburg MA, Cash-Goldwasser S, Yu Y, et al. Interim clinical treatment considerations for severe manifestations of mpox-United States, February 2023. MMWR Morb Mortal Wkly Rep. 2023; 72(9):232-43. [DOI:10.15585/mmwr.mm7209a4] [PMID]##WHO. Clinical management and infection prevention and control guideline. Geneva 2025. [Link]##Edghill-Smith Y, Golding H, Manischewitz J, King LR, Scott D, Bray M, et al. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med. 2005; 11(7):740-7. [DOI:10.1038/nm1261] [PMID]##Earl PL, Americo JL, Wyatt LS, Eller LA, Whitbeck JC, Cohen GH, et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature. 2004; 428(6979):182-5. [DOI:10.1038/nature02331] [PMID]##FDA. FDA Roundup: August 30, 2024. Maryland: FDA; 2024. [Link]##WHO. WHO prequalifies the first vaccine against mpox. Geneva: WHO; 2024. [Link]##Russo AT, Grosenbach DW, Brasel TL, Baker RO, Cawthon AG, Reynolds E, et al. Effects of treatment delay on efficacy of tecovirimat following lethal aerosol monkeypox virus challenge in cynomolgus macaques. J Infect Dis. 2018; 218(9):1490-9. [DOI:10.1093/infdis/jiy326] [PMID]##Lam HYI, Guan JS, Mu Y. In silico repurposed drugs against monkeypox virus. Molecules. 2022; 27(16):5277. [DOI:10.3390/molecules27165277] [PMID]##Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021; 596(7873):583-9. [DOI:10.1038/s41586-021-03819-2] [PMID]##Meng EC, Goddard TD, Pettersen EF, Couch GS, Pearson ZJ, Morris JH, et al. UCSF ChimeraX: Tools for structure building and analysis. Protein Sci. 2023; 32(11):e4792.[DOI:10.1002/pro.4792] [PMID]##Mirdita M, Schütze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: Making protein folding accessible to all. Nat Methods. 2022; 19(6):679-82. [DOI:10.1038/s41592-022-01488-1] [PMID]##Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. [DOI:10.1002/jcc.20084] [PMID]##Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem 2023 update. Nucleic Acids Res. 2023; 51(D1):D1373-80. [DOI:10.1093/nar/gkac956] [PMID]##Hinchliffe A. CS Chem3D Pro 3.5 and CS MOPAC Pro (Mac and Windows) UK. New Jersey: Wiley; 1997. [DOI:10.1002/ejtc.54]##Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2. 0: New docking methods, expanded force field, and python bindings. J Chem Inf Model. 2021; 61(8):3891-8. [DOI:10.1021/acs.jcim.1c00203] [PMID]##Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol. 2015; 1263:243-50. [DOI:10.1007/978-1-4939-2269-7_19] [PMID]##Lokhande KB, Shrivastava A, Singh A. In silico discovery of potent inhibitors against monkeypox’s major structural proteins. J Biomol Struct Dyn. 2023; 41(23):14259-74. [DOI:10.1080/07391102.2023.2183342] [PMID]##Schrödinger L. The PyMOL Molecular Graphics System.Version. 2015; 1:8. [Link]##BIOVIA, Dassault systèmes. Discovery studio visualizer v21.1.0.20298. San Diego: Dassault Systèmes Biovia Corp; 2021. [Link]##Maredia H, Sartori-Valinotti JC, Ranganath N, Tosh PK, O’Horo JC, Shah AS. Supportive care management recommendations for mucocutaneous manifestations of monkeypox infection. Mayo Clin Proc. 2023; 98(6):828-32.[DOI:10.1016/j.mayocp.2023.01.019] [PMID]##Mucker EM, Goff AJ, Shamblin JD, Grosenbach DW, Damon IK, Mehal JM, et al. Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox). Antimicrob Agents Chemother. 2013; 57(12):6246-53. [DOI:10.1128/AAC.00977-13] [PMID]##Magee WC, Hostetler KY, Evans DH. Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate. Antimicrob Agents Chemother. 2005; 49(8):3153-62. [DOI:10.1128/AAC.49.8.3153-3162.2005] [PMID]##Centers for Disease Control and Prevention (CDC). Mpox treatment information for healthcare professionals.: Atlanta: CDC; 2023. [Link]##Priyanka NS, Neeraja P, Mangilal T, Kumar MR. Formulation and evaluation of gel loaded with microspheres of apremilast for transdermal delivery system. Asian J Pharm Clin Res. 2019; 12(2):411-7. [DOI:10.22159/ajpcr.2019.v12i2.29374]##Zhou J, Krishnan N, Jiang Y, Fang RH, Zhang L. Nanotechnology for virus treatment. Nano Today. 2021; 36:101031.[DOI:10.1016/j.nantod.2020.101031] [PMID]##Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: Progress, challenges and recommendations. Nat Rev Drug Discov. 2019; 18(1):41-58. [DOI:10.1038/nrd.2018.168] [PMID]##Alarfaj SJ, Alzahrani A, Alotaibi A, Almutairi M, Hakami M, Alhomaid N, et al. The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia. Saudi Pharm J. 2022; 30(10):1448-53. [DOI:10.1016/j.jsps.2022.07.005] [PMID]##Kowdley KV, Gordon SC, Reddy KR, Rossaro L, Bernstein DE, Lawitz E, et al. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. N Engl J Med. 2014; 370(20):1879-88. [DOI:10.1056/NEJMoa1402355] [PMID]##Dodaro A, Pavan M, Moro S. Targeting the I7L Protease: A rational design for Anti-Monkeypox Drugs? Int J Mol Sci. 2023; 24(8):7119. [DOI:10.3390/ijms24087119] [PMID]##DrugBank. Open Data Drug &#38; Drug Target Database (version 5.1.12) [Internet]. 2024 [Updated 9 November 2025]. Available from: [Link]##Hu Z, Guan Y, Hu W, Xu Z, Ishfaq M. An overview of pharmacological activities of baicalin and its aglycone baicalein: New insights into molecular mechanisms and signaling pathways. Iran J Basic Med Sci. 2022; 25(1):14-26. [DOI:10.22038/IJBMS.2022.60380.13381] [PMID]## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>A Retrospective Analysis of Adverse Drug Reactions at a Tertiary Care Center–patterns, Causality, Predictability, and Preventability</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Adverse drug reactions (ADRs) are associated with significant morbidity and mortality. They can negatively impact healthcare resources and cause financial burden on patients.&#160;
Objectives: This study aimed to assess the causality, severity, predictability, and preventability of reported ADRs as per standard scales.
Methods: A retrospective observational study was conducted in KRIMS, Karwar, from April 2018 to August 2019. All suspected ADRs reported by outpatients and inpatients of various clinical departments were collected and analyzed.
Results: A total of 159 ADRs were reported in 136 patients. Most patients were adults aged 18-65 years (88.2%). A female preponderance was observed. The skin and central nervous system (CNS) were the predominant organ systems affected (29.6% each). The most common ADRs reported were rashes (14.5%) followed by sedation (8.2%). Antibiotics were the most commonly used drug class (38.5%). Among the individual drugs, &#946;-lactam antibiotics were the most commonly implicated (16%). Most drugs causing ADRs were administered orally (67.5%). The causality of the reported ADRs was probable in 64.2%. Most of the reported ADRs were non-serious (91.2%). A total of 61% of patients experiencing ADRs recovered completely. Of the ADRs, 83.6% were mild, 51.6% were predictable, and 85.5% were not preventable. Most ADRs subsided after withdrawing the offending drug (66.7%).&#160;
Conclusion: Early detection of the causal relationship between drugs and adverse reactions is crucial for their effective management and prevention.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>261</FPAGE>
			<TPAGE>270</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2025/07/122025/01/252025/02/172023/06/82025/01/212024/11/142025/04/162025/04/26
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1404/2/6
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2025/09/212025/07/192025/08/162025/04/262025/07/192025/08/162025/09/302025/09/21
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1404/6/30
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>M R</Name>
				<MidName></MidName>
				<Family>Manasa</Family>
				<NameE>M R</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Manasa</FamilyE>
				<Organizations>
				<Organization>Karwar Institute of Medical Sciences</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>dr.manasamr@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Chaitanya</Name>
				<MidName></MidName>
				<Family>Karant</Family>
				<NameE>Chaitanya</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Karant</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Karwar Institute of Medical Sciences, Karwar, India.</Organization>
				</Organizations>
				<Countries>
				<Country>India</Country>
				</Countries>
				<EMAILS>
				<Email>chaithu.bargi18@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>BVS</Name>
				<MidName></MidName>
				<Family>Chandrasekhar</Family>
				<NameE>BVS</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Chandrasekhar</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, GSL Medical College and General Hospital, Rajahmundry, India.</Organization>
				</Organizations>
				<Countries>
				<Country>India</Country>
				</Countries>
				<EMAILS>
				<Email>sekharpharma9@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Swetha</Name>
				<MidName></MidName>
				<Family>K</Family>
				<NameE>Swetha</NameE>
				<MidNameE></MidNameE>
				<FamilyE>K</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, Yadgiri Institute of Medical Sciences, Yadgiri, India.</Organization>
				</Organizations>
				<Countries>
				<Country>India</Country>
				</Countries>
				<EMAILS>
				<Email>drswethak27@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Adverse drug reactions (ADRs)</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Causality</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Retrospective</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Prevention</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>World Health Organization. Safety of medicines: A guide to detecting and reporting adverse drug reactions why health professionals need to take action. Geneva: World Health Organization; 2002. [Link]##Arulmani R, Rajendran SD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol. 2008; 65(2):210-6. [DOI:10.1111/j.1365-2125.2007.02993.x] [PMID]##Mangla R, Verma S, Gupta MC, Singhal S. Adverse drug reaction monitoring of commonly prescribed medicines in gynaecology patients in a tertiary care hospital in North India. Int J Health Sci Res. 2017; 7(11):111-7. [Link]##Patiyal N, Gautam A, Kansal D, Sood A, Chauhan A, Bodh S. Pattern of adverse drug effects reported by patients being treated in a tertiary healthcare institution in North India: A retrospective observational study. IP Int J Comprehensive Adv Pharmacol. 2022; 7(2):87-90. [DOI:10.18231/j.ijcaap.2022.016]##Singh H, Dulhani N, Kumar BN, Singh P, Tewari P, Nayak K. A Pharmacovigilance study in medicine department of tertiary care hospital in Chhattisgarh (Jagdalpur), India. J Young Pharm. 2010; 2(1):95-100. [DOI:10.4103/0975-1483.62222] [PMID]##World Health Organization. Medicines: Safety of medicines - adverse drug reactions. Geneva: WHO; 2008. [Link]##Agada PO, Eyong AK, Asukwo EO, Irene C. Incidence of adverse drug reactions in patients on antiretroviral therapy: a study of pharmaceutical care in HIV interventions in a tertiary health facility in southern Nigeria. Res Human Soc Sci. 2016; 6(14):103-7. [Link]##Joseph SG, Badyal DK. Spontaneous adverse drug reaction monitoring in a tertiary care hospital in Northern India. JK Sci. 2016; 18(2):103-6. [Link]##World Health Organization. The safety of medicines in public health programmes: Pharmacovigilance an essential tool. Geneva: World Health Organization; 2006. [Link]##World Health Organization. The Use of the WHO-UMC System for Standardised Case Causality Assessment. Geneva: World Health Organization; 2013. [Link]##Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992; 49:2229-32. [DOI:10.1093/ajhp/49.9.2229] [PMID]##Raut AL, Patel P, Patel C, Pawar A. Preventability, predictability and seriousness of adverse drug reactions amongst medicine inpatients in a teaching hospital: A prospective observational study. Int J Pharm Chem Sci. 2012; 1(3):1293-9.[Link]##Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992; 27(6):538. [PMID]##Prajapati H, Kansal D, Chaudhary UK. Pattern of adverse drug reactions in rural tertiary care medical college and hospital of Himachal Pradesh: A retrospective observational study. Indian J Pharm Pharmacol. 2018; 5(1):4-6. [DOI:10.18231/2393-9087.2018.0002]##Gupta A, Kaur A, Shukla P, Chhabra H. Adverse Drug Reactions pattern in a tertiary level teaching hospital: A Retrospective Study. Indian J Pharm Pract. 2017; 10(1):27-31. [Link]##Bhattacharjee P, Das L, Ghosh R, Lalromawii, Das UK. Pattern of adverse drug reactions reported at a tertiary health care teaching hospital of Tripura: A retrospective study. Int J Basic Clin Pharmacol. 2016; 5(4):1293-99. [DOI:10.18203/2319-2003.ijbcp20162177]##Singh A, Jain A, Soni M, Shukla P, Lahon J, Verma AK. Pattern of adverse drug reactions reported at a tertiary care teaching hospital in northern India. Int J Basic Clin Pharmacol. 2020; 9(4)625-32. [DOI:10.18203/2319-2003.ijbcp20201189]##Behera SK, Rath B, Biswal SB, Mohapatra S. Pattern of adverse drug reactions in a tertiary care hospital in Western Odisha. Int J Pharm Sci Res. 2018; 9(6):2471-7. [Link]##Bhandare B, Shabeer D, Satyanarayana V. A study on adverse drug reactions in a tertiary care hospital in Bangalore. Indian J Pharm Pharmacol. 2017; 4(1):49-54. [Link]##Patidar D, Rajput MS, Nirmal NP, Savitri W. Implementation and evaluation of adverse drug reaction monitoring system in a tertiary care teaching hospital in Mumbai, India. Interdiscip Toxicol. 2013; 6(1):41-6. [DOI:10.2478/intox-2013-0008] [PMID]##Agrawal M, Hishikar R, Joshi U, Halwai A, Toddar TL, Khubchandani V. Adverse drug reaction scenario at ADR Monitoring Centre of Tertiary Teaching Hospital at Raipur. Indian J Pharm Pharmacol. 2015; 2(3):169-75. [Link]##Khan LM, Al-Harthi SE, Saadah OI. Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR. Saudi Pharm J. 2013; 21(3):261-6. [DOI:10.1016/j.jsps.2012.09.004] [PMID]##Bhabhor PH, Patel TK, Vahora R, Patel PB, Desai N. Adverse drug reactions in a tertiary care teaching hospital in India: Analysis of spontaneously reported cases. Int J Basic Clin Pharmacol. 2017; 3(6):1078-85. [DOI:10.5455/2319-2003.ijbcp20141228]##Kaur M, Deb T, Kairi J, Arora A. A pharmacovigilance study of adverse drug reactions in a tertiary care hospital in Haryana. Int J Basic Clin Pharmacol. 2019; 8(10):2184–90.[DOI:10.18203/2319-2003.ijbcp20194149]##Keche Y, Gaikwad N, Dhaneria S. Preventability, predictability, severity and causality assessment of adverse drug reactions reported from a teaching hospital in chhattisgarh: A retrospective analysis. J Family Med Prim Care. 2021; 10(7):2541-5. [DOI:10.4103/jfmpc.jfmpc_2374_20] [PMID]##Shamna M, Dilip C, Ajmal M, Linu PM, Shinu C, Jafer CP, et al. A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital. Saudi Pharm J. 2014; 22(4):303-8. [PMID]##Pathak AK, Kumar M, Dokania S, Mohan L, Dikshit H. A retrospective analysis of reporting of adverse drug reactions in a Tertiary Care Teaching Hospital: One Year Survey. J Clin Diagn Res. 2016; 10(8):FC01-4. [DOI:10.7860/JCDR/2016/18826.8284] [PMID]##Lihite RJ, Lahkar M, Das S, Hazarika D, Kotni M, Maqbool M, et al. A study on adverse drug reactions in a tertiary care hospital of Northeast India. Alexandria J Med. 2017; 53(2):151-6. [DOI:10.1016/j.ajme.2016.05.007]##Venkatasubbaiah M, Reddy PD, Satyanarayana SV. Analysis and reporting of adverse drug reactions at a tertiary care teaching hospital Alexandria J Med. 2018; 54(4):597-603. [DOI:10.1016/j.ajme.2018.10.005]##Badyal DK, Kanish B, Gulrez G. Causality assessment and pattern of adverse drug reactions in a tertiary care hospital. Int J Basic Clin Pharmacol. 2018; 7(2):210-4. [DOI:10.18203/2319-2003.ijbcp20180089]##Singh P, Agrawal M, Hishikar R, Joshi U, Maheshwari B, Halwai A. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year. Indian J Pharmacol. 2017; 49(6):432-7. [DOI:10.4103/ijp.IJP_781_16] [PMID]##Ramnath SN, Nair PV, Philip MM, Palappallil DS. Adverse drug reactions reported to an ADR monitoring centre as a part of the Pharmacovigilance Programme of India: A retrospective analysis of 3-year data. Natl J Physiol Pharm Pharmacol. 2023; 13(09):1893-7. [DOI:10.5455/njppp.2023.13.07344202323072023]##Sen M, Singh A, Misra M. Retrospective analysis of adverse drug reactions reported at ADR monitoring centre under PvPI in a tertiary care hospital. Int J Basic Clin Pharmacol. 2018; 7(2):303–8. [DOI:10.18203/2319-2003.ijbcp20180103]##James J, Rani J. A prospective study of adverse drug reactions in a tertiary care hospital in South India. Asian J Pharm Clin Res. 2020; 13(1):89-92. [DOI:10.22159/ajpcr.2020.v13i1.36028]##Sudha TYS, Vangoori Y, Varghese AV. A profile of adverse drug reactions in a tertiary care teaching hospital and associated factors. Biomed Pharmacol J. 2021; 14(1):367-71. [DOI:10.13005/bpj/2135]##Vemuri VR. A retrospective and observational study of the adverse drug reactions reported in a tertiary care hospital. Int J Basic Clin Pharmacol. 2024; 13(2):213-8. [DOI:10.18203/2319-2003.ijbcp20240033]##Tongaonkar A, Joshi K, Mulkalwar A, Dagli S. Clinical profile of adverse drug reactions in patients admitted to internal medicine wards of a tertiary care hospital. Int J Acad Med. 2023; 9(4):185-91. [DOI:10.4103/ijam.ijam_18_23]## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Urinary Incontinence During Sleep Associated With Buspirone: A Case Report</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Buspirone is an anxiolytic medication that selectively alleviates anxiety without the anticonvulsant, sedative, or muscle-relaxant effects associated with benzodiazepine. To the best of our knowledge, case reports of nocturnal urinary incontinence in buspirone users have not yet been&#160;published.&#160;
Case Report: We report a 52-year-old female patient with urinary incontinence during sleep (once or twice a week) associated with buspirone (10 mg/day). The patient&#8217;s nocturnal enuresis problem disappeared immediately after the discontinuation of buspirone.&#160;
Conclusion: The mechanism underlying this effect is known. These medications influence neurotransmitter systems that modulate bladder control, altering micturition patterns. Antidepressants affect central nervous system pathways that regulate bladder function, potentially decreasing inhibitory control and increasing detrusor muscle sensitivity. Reporting rare drug side effects is crucial for enhancing patient safety and improving pharmacovigilance.&#160;</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>271</FPAGE>
			<TPAGE>276</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2025/07/122025/01/252025/02/172023/06/82025/01/212024/11/142025/04/162025/04/262025/05/18
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1404/2/28
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2025/09/212025/07/192025/08/162025/04/262025/07/192025/08/162025/09/302025/09/212025/09/30
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1404/7/8
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Seyed Hamzeh</Name>
				<MidName></MidName>
				<Family>Hosseini</Family>
				<NameE>Seyed Hamzeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hosseini</FamilyE>
				<Organizations>
				<Organization>Department of Psychiatry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>hosseinish20@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hamed</Name>
				<MidName></MidName>
				<Family>Ghazvini</Family>
				<NameE>Hamed</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghazvini</FamilyE>
				<Organizations>
				<Organization>Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>hghazvini1@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Seyedeh Masoumeh Seyedhosseini</Name>
				<MidName></MidName>
				<Family>Tamijani</Family>
				<NameE>Seyedeh Masoumeh Seyedhosseini</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Tamijani</FamilyE>
				<Organizations>
				<Organization>Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>Seyedhoseini_sm@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Raheleh</Name>
				<MidName></MidName>
				<Family>Rafaiee</Family>
				<NameE>Raheleh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rafaiee</FamilyE>
				<Organizations>
				<Organization>Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>rachel.rafaie@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Urinary incontinence</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Nocturnal enuresis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Buspirone</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Case reports</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Basile AS, Lippa AS, Skolnick P. Anxioselective anxiolytics: Can less be more? Eur J Pharmacol. 2004; 500(1-3):441-51. [DOI:10.1016/j.ejphar.2004.07.043] [PMID]##Gunter BW. Evaluation of the anxiolytic-like, abuse-related, and sedative/motor effects of benzodiazepine and neuroactive steroid combinations in rats [PhD dissertation]. Mississippi: University of Mississippi Medical Center; 2015. [Link]##Smith ALW, Harmer CJ, Cowen PJ, Murphy SE. The Serotonin 1A (5-HT1A) receptor as a pharmacological target in depression. CNS Drugs. 2023; 37(7):571-85. [DOI:10.1007/s40263-023-01014-7] [PMID]##Dhavalshankh AG, Dhavalshankh GP. Psychopharmacological Profile of Buspirone: A critical overview. J Pharm Res. 2012; 5(8):3973-80. [Link]##Loane C, Politis M. Buspirone: What is it all about? Brain Res. 2012; 1461:111-8. [DOI:10.1016/j.brainres.2012.04.032] [PMID]##Shenoi SD, Soman S, Munoli R, Prabhu S. Update on pharmacotherapy in psychodermatological disorders. Indian Dermatol Online J. 2020; 11(3):307-18. [DOI:10.4103/idoj.IDOJ_330_19] [PMID]##Haleem DJ, Nawaz S, Salman T. Dose related effects of buspirone on pain, learning / memory and food intake. Regul Toxicol Pharmacol. 2018; 99:182-90. [DOI:10.1016/j.yrtph.2018.09.017] [PMID]##Hutka P, Krivosova M, Muchova Z, Tonhajzerova I, Hamrakova A, Mlyncekova Z, et al. Association of sleep architecture and physiology with depressive disorder and antidepressants treatment. Int J Mol Sci. 2021; 22(3):1333. [DOI:10.3390/ijms22031333] [PMID]##Misra AK, Sharma PK. Sedative and hypnotic drugs. In: Uddin S, Rashid M, editor. Advances in neuropharmacology: Drugs and therapeutics. Massachusetts: Apple Academic Press; 2020. [DOI:10.1201/9780429242717-13]##Barnett SR, Riddle MA. Anxiolytics and sedative/hypnotics: Benzodiazepines, buspirone, and others. In: Martin A, Scahill L, Kratochvil Ch, editors. Pediatric psychopharmacology. Oxford: Oxford Academic; 2010. [DOI:10.1093/med/9780195398212.003.0024]##Drugs.com. Buspirone Side effects [Internet]. 2025 [Updated 22 May 2025]. Available from: [Link]##Medscape. buspirone (Rx) [Internet[. New York: Medscape; 2025. [Link]##Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006; 354(12):1243-52 [DOI:10.1056/NEJMoa052964] [PMID]##Movig KL, Leufkens HG, Belitser SV, Lenderink AW, Egberts AC. Selective serotonin reuptake inhibitor‐induced urinary incontinence. Pharmacoepidemiol Drug Saf. 2002; 11(4):271-9. [DOI:10.1002/pds.705] [PMID]##Breinbjerg A, Jørgensen CS, Borg B, Rittig S, Kamperis K, Christensen JH. The genetics of incontinence: A scoping review. Clin Genet. 2023; 104(1):22-62. [DOI:10.1111/cge.14331] [PMID]##Coyne KS, Kaplan SA, Chapple CR, Sexton CC, Kopp ZS, Bush EN, et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int. 2009; 103(Suppl 3):24-32. [DOI:10.1111/j.1464-410X.2009.08438.x] [PMID]##Tsakiris P, Oelke M, Michel MC. Drug-induced urinary incontinence. Drugs Aging. 2008; 25(7):541-9. [DOI:10.2165/00002512-200825070-00001] [PMID]##Shaw C, Wagg A. Urinary incontinence in older adults. Medicine. 2017; 45(1):23-7. [DOI:10.1016/j.mpmed.2016.10.001]##Noël S, Claeys S, Hamaide A. Acquired urinary incontinence in the bitch: update and perspectives from human medicine. Part 2: The urethral component, pathophysiology and medical treatment. Vet J. 2010; 186(1):18-24. [DOI:10.1016/j.tvjl.2010.06.011] [PMID]##Yoshimura N, Takaoka E, Suzuki T, Kwon J. Pharmacology of the Lower Urinary Tract. In: Liao L, Madersbacher H, editors. Neurourology. Dordrecht: Springer; 2019. [DOI:10.1007/978-94-017-7509-0_8]##Andersson KE, Pehrson R. CNS involvement in overactive bladder: Pathophysiology and opportunities for pharmacological intervention. Drugs. 2003; 63(23):2595-611. [DOI:10.2165/00003495-200363230-00003] [PMID]##Chung AS, Cheng JN, Tse V. Psychotropic drugs and their effects on lower urinary tract function: An update. Curr Bladder Dysfunct Rep. 2016; 11:258-65. [DOI:10.1007/s11884-016-0372-5]##Postuma RB, Gagnon JF, Tuineaig M, Bertrand JA, Latreille V, Desjardins C, et al. Antidepressants and REM sleep behavior disorder: Isolated side effect or neurodegenerative signal? Sleep. 2013; 36(11):1579-85. [DOI:10.5665/sleep.3102] [PMID]## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>

</ARTICLES>

</JOURNAL>
</XML>
